Search Name:	V20130429-03 BS p197-1 no/results1
			V20130429-03 BS p197-1 no/results1																					
	Uniq Pep	Acc #	UniProt ID	Gene	Num Unique	% Cov	Best Disc Score	Best Expect Val	m/z	z	ppm	DB Peptide	Peptide	Protein Mods	Length	Fraction	RT	Start	End	Score	Expect	P Value	# in DB	Protein MW	Species	Protein Name
[1]		P04406	G3P_HUMAN	GAPDH	16	62.1	10.14	3.6e-18	871.1232	3	0.076	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLM(Oxidation)TTVHAITATQK	Oxidation@175	24	V20130429-03_FTMSms2hcd	62.057	163	186	60.5	3.6e-18	6.0e-21	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	16	62.1	10.14	3.6e-18	756.0618	3	1.2	LTGMAFRVPTANVSVVDLTCR	LTGM(Oxidation)AFRVPTANVSVVDLTCR	Oxidation@231	21	V20130429-03_FTMSms2hcd	52.954	228	248	49.9	7.5e-18	1.2e-20	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	16	62.1	10.14	3.6e-18	845.4089	3	0.085	IKWGDAGAEYVVESTGVFTTMEK	IKWGDAGAEYVVESTGVFTTM(Oxidation)EK	Oxidation@105	23	V20130429-03_FTMSms2hcd	54.235	85	107	49.5	4.3e-15	4.1e-18	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	16	62.1	10.14	3.6e-18	882.4064	2	1.8	LISWYDNEFGYSNR	LISWYDNEFGYSNR		14	V20130429-03_FTMSms2hcd	49.865	310	323	57.1	1.9e-14	2.1e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	16	62.1	10.14	3.6e-18	1004.7290	4	1.5	AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGK	AAFNSGKVDIVAINDPFIDLNYM(Oxidation)VYM(Oxidation)FQYDSTHGK	Oxidation@43;Oxidation@46	35	V20130429-03_FTMSms2hcd	68.998	21	55	47.7	2.1e-14	2.4e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	16	62.1	10.14	3.6e-18	681.8228	2	-0.64	VVDLMAHMASKE	VVDLM(Oxidation)AHM(Oxidation)ASKE	Oxidation@328;Oxidation@331	12	V20130429-03_FTMSms2hcd	16.567	324	335	39.1	4.7e-14	6.3e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	16	62.1	10.14	3.6e-18	847.4548	3	1.2	AENGKLVINGNPITIFQERDPSK	AENGKLVINGNPITIFQERDPSK		23	V20130429-03_FTMSms2hcd	48.769	62	84	52.2	4.8e-14	1.1e-16	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	16	62.1	10.14	3.6e-18	865.7933	3	2.1	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLMTTVHAITATQK		24	V20130429-03_FTMSms2hcd	71.287	163	186	45.0	9.8e-13	2.2e-15	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	16	62.1	10.14	3.6e-18	1000.7332	4	4.4	AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGK	AAFNSGKVDIVAINDPFIDLNYM(Oxidation)VYMFQYDSTHGK	Oxidation@43=22	35	V20130429-03_FTMSms2hcd	71.675	21	55	39.4	2.7e-12	3.2e-15	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	16	62.1	10.14	3.6e-18	681.0397	3	-1.5	LVINGNPITIFQERDPSK	LVINGNPITIFQERDPSK		18	V20130429-03_FTMSms2hcd	52.542	67	84	37.8	1.3e-9	3.1e-12	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	16	62.1	10.14	3.6e-18	706.3969	2	-2.7	GALQNIIPASTGAAK	GALQNIIPASTGAAK		15	V20130429-03_FTMSms2hcd	39.054	201	215	36.6	2.2e-9	5.8e-12	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	16	62.1	10.14	3.6e-18	737.3908	2	0.91	VPTANVSVVDLTCR	VPTANVSVVDLTCR		14	V20130429-03_FTMSms2hcd	43.643	235	248	52.0	3.4e-9	5.4e-12	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	16	62.1	10.14	3.6e-18	749.0392	3	1.7	VIISAPSADAPMFVMGVNHEK	VIISAPSADAPM(Oxidation)FVM(Oxidation)GVNHEK	Oxidation@130;Oxidation@133	21	V20130429-03_FTMSms2hcd	41.691	119	139	23.1	8.3e-8	8.9e-11	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	16	62.1	10.14	3.6e-18	362.7104	4	2.9	LEKPAKYDDIKK	LEKPAKYDDIKK		12	V20130429-03_FTMSms2hcd	14.732	249	260	24.6	8.8e-8	3.0e-10	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	16	62.1	10.14	3.6e-18	403.2198	2	1.0	VGVNGFGR	VGVNGFGR		8	V20130429-03_FTMSms2hcd	22.519	6	13	37.0	1.5e-6	2.8e-9	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	16	62.1	10.14	3.6e-18	835.8953	4	1.6	VDIVAINDPFIDLNYMVYMFQYDSTHGK	VDIVAINDPFIDLNYM(Oxidation)VYM(Oxidation)FQYDSTHGK	Oxidation@43;Oxidation@46	28	V20130429-03_FTMSms2hcd	71.969	28	55	10.9	1.6e-4	1.5e-7	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P63261	ACTG_HUMAN	ACTG1	10	35.5	12.19	5.7e-22	918.9218	2	0.51	MEEEIAALVIDNGSGMCK	M(Met-loss+Acetyl)EEEIAALVIDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-03_FTMSms2hcd	60.696	1	18	53.8	5.7e-22	6.3e-25	1	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	10	35.5	12.19	5.7e-22	790.9051	2	0.43	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@313;Oxidation@325	14	V20130429-03_FTMSms2hcd	23.331	313	326	51.3	9.5e-17	1.2e-19	6	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	10	35.5	12.19	5.7e-22	677.8158	2	0.72	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-03_FTMSms2hcd	12.470	51	62	45.5	1.6e-13	2.1e-16	6	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	10	35.5	12.19	5.7e-22	895.9503	2	0.78	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-03_FTMSms2hcd	48.047	239	254	50.5	2.0e-13	2.3e-16	10	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	10	35.5	12.19	5.7e-22	977.5381	2	2.3	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-03_FTMSms2hcd	41.277	96	113	50.9	1.4e-12	4.0e-15	2	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	10	35.5	12.19	5.7e-22	800.6579	4	0.17	TTGIVMDSGDGVTHTVPIYEGYALPHAILR	TTGIVM(Oxidation)DSGDGVTHTVPIYEGYALPHAILR	Oxidation@153	30	V20130429-03_FTMSms2hcd	53.621	148	177	38.0	1.8e-12	2.4e-15	2	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	10	35.5	12.19	5.7e-22	589.3124	2	3.6	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-03_FTMSms2hcd	25.376	316	326	40.0	2.7e-10	4.1e-13	6	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	10	35.5	12.19	5.7e-22	507.7446	2	0.69	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@190	8	V20130429-03_FTMSms2hcd	38.030	184	191	25.1	1.1e-9	2.1e-12	7	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	10	35.5	12.19	5.7e-22	400.2404	3	0.95	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-03_FTMSms2hcd	35.537	29	39	41.4	6.7e-9	2.4e-11	9	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	10	35.5	12.19	5.7e-22	400.7728	2	3.8	RGILTLK	RGILTLK		7	V20130429-03_FTMSms2hcd	25.715	62	68	17.9	0.011	8.1e-5	10	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P60709	ACTB_HUMAN	ACTB	10	35.5	12.03	1.1e-21	890.8918	2	2.0	MDDDIAALVVDNGSGMCK	M(Met-loss+Acetyl)DDDIAALVVDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-03_FTMSms2hcd	52.568	1	18	47.9	1.1e-21	1.5e-24	1	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	10	35.5	12.03	1.1e-21	790.9051	2	0.43	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@313;Oxidation@325	14	V20130429-03_FTMSms2hcd	23.331	313	326	51.3	9.5e-17	1.2e-19	6	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	10	35.5	12.03	1.1e-21	677.8158	2	0.72	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-03_FTMSms2hcd	12.470	51	62	45.5	1.6e-13	2.1e-16	6	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	10	35.5	12.03	1.1e-21	895.9503	2	0.78	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-03_FTMSms2hcd	48.047	239	254	50.5	2.0e-13	2.3e-16	10	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	10	35.5	12.03	1.1e-21	977.5381	2	2.3	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-03_FTMSms2hcd	41.277	96	113	50.9	1.4e-12	4.0e-15	2	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	10	35.5	12.03	1.1e-21	800.6579	4	0.17	TTGIVMDSGDGVTHTVPIYEGYALPHAILR	TTGIVM(Oxidation)DSGDGVTHTVPIYEGYALPHAILR	Oxidation@153	30	V20130429-03_FTMSms2hcd	53.621	148	177	38.0	1.8e-12	2.4e-15	2	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	10	35.5	12.03	1.1e-21	589.3124	2	3.6	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-03_FTMSms2hcd	25.376	316	326	40.0	2.7e-10	4.1e-13	6	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	10	35.5	12.03	1.1e-21	507.7446	2	0.69	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@190	8	V20130429-03_FTMSms2hcd	38.030	184	191	25.1	1.1e-9	2.1e-12	7	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	10	35.5	12.03	1.1e-21	400.2404	3	0.95	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-03_FTMSms2hcd	35.537	29	39	41.4	6.7e-9	2.4e-11	9	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	10	35.5	12.03	1.1e-21	400.7728	2	3.8	RGILTLK	RGILTLK		7	V20130429-03_FTMSms2hcd	25.715	62	68	17.9	0.011	8.1e-5	10	41737.1	HUMAN	Actin, cytoplasmic 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	9	32.4	9.37	9.5e-17	790.9051	2	0.43	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-03_FTMSms2hcd	23.331	315	328	51.3	9.5e-17	1.2e-19	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	9	32.4	9.37	9.5e-17	677.8158	2	0.72	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-03_FTMSms2hcd	12.470	53	64	45.5	1.6e-13	2.1e-16	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	9	32.4	9.37	9.5e-17	895.9503	2	0.78	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-03_FTMSms2hcd	48.047	241	256	50.5	2.0e-13	2.3e-16	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	9	32.4	9.37	9.5e-17	869.1667	4	2.2	YPIEHGIITNWDDMEKIWHHTFYNELR	YPIEHGIITNWDDM(Oxidation)EKIWHHTFYNELR	Oxidation@84	27	V20130429-03_FTMSms2hcd	54.061	71	97	31.6	2.5e-10	2.6e-13	2	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	9	32.4	9.37	9.5e-17	589.3124	2	3.6	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-03_FTMSms2hcd	25.376	318	328	40.0	2.7e-10	4.1e-13	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	9	32.4	9.37	9.5e-17	507.7446	2	0.69	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@192	8	V20130429-03_FTMSms2hcd	38.030	186	193	25.1	1.1e-9	2.1e-12	7	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	9	32.4	9.37	9.5e-17	400.2404	3	0.95	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-03_FTMSms2hcd	35.537	31	41	41.4	6.7e-9	2.4e-11	9	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	9	32.4	9.37	9.5e-17	1049.8024	3	-17	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=37	28	V20130429-03_FTMSms2hcd	59.435	259	286	17.2	1.2e-5	1.2e-8	4	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	9	32.4	9.37	9.5e-17	400.7728	2	3.8	RGILTLK	RGILTLK		7	V20130429-03_FTMSms2hcd	25.715	64	70	17.9	0.011	8.1e-5	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	9	32.4	9.37	9.5e-17	790.9051	2	0.43	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-03_FTMSms2hcd	23.331	315	328	51.3	9.5e-17	1.2e-19	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	9	32.4	9.37	9.5e-17	677.8158	2	0.72	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-03_FTMSms2hcd	12.470	53	64	45.5	1.6e-13	2.1e-16	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	9	32.4	9.37	9.5e-17	895.9503	2	0.78	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-03_FTMSms2hcd	48.047	241	256	50.5	2.0e-13	2.3e-16	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	9	32.4	9.37	9.5e-17	869.1667	4	2.2	YPIEHGIITNWDDMEKIWHHTFYNELR	YPIEHGIITNWDDM(Oxidation)EKIWHHTFYNELR	Oxidation@84	27	V20130429-03_FTMSms2hcd	54.061	71	97	31.6	2.5e-10	2.6e-13	2	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	9	32.4	9.37	9.5e-17	589.3124	2	3.6	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-03_FTMSms2hcd	25.376	318	328	40.0	2.7e-10	4.1e-13	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	9	32.4	9.37	9.5e-17	507.7446	2	0.69	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@192	8	V20130429-03_FTMSms2hcd	38.030	186	193	25.1	1.1e-9	2.1e-12	7	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	9	32.4	9.37	9.5e-17	400.2404	3	0.95	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-03_FTMSms2hcd	35.537	31	41	41.4	6.7e-9	2.4e-11	9	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	9	32.4	9.37	9.5e-17	1049.8024	3	-17	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=37	28	V20130429-03_FTMSms2hcd	59.435	259	286	17.2	1.2e-5	1.2e-8	4	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	9	32.4	9.37	9.5e-17	400.7728	2	3.8	RGILTLK	RGILTLK		7	V20130429-03_FTMSms2hcd	25.715	64	70	17.9	0.011	8.1e-5	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	8	25.2	9.37	9.5e-17	790.9051	2	0.43	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-03_FTMSms2hcd	23.331	315	328	51.3	9.5e-17	1.2e-19	6	42009.4	HUMAN	Actin, aortic smooth muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	8	25.2	9.37	9.5e-17	677.8158	2	0.72	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-03_FTMSms2hcd	12.470	53	64	45.5	1.6e-13	2.1e-16	6	42009.4	HUMAN	Actin, aortic smooth muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	8	25.2	9.37	9.5e-17	895.9503	2	0.78	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-03_FTMSms2hcd	48.047	241	256	50.5	2.0e-13	2.3e-16	10	42009.4	HUMAN	Actin, aortic smooth muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	8	25.2	9.37	9.5e-17	589.3124	2	3.6	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-03_FTMSms2hcd	25.376	318	328	40.0	2.7e-10	4.1e-13	6	42009.4	HUMAN	Actin, aortic smooth muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	8	25.2	9.37	9.5e-17	507.7446	2	0.69	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@192	8	V20130429-03_FTMSms2hcd	38.030	186	193	25.1	1.1e-9	2.1e-12	7	42009.4	HUMAN	Actin, aortic smooth muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	8	25.2	9.37	9.5e-17	400.2404	3	0.95	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-03_FTMSms2hcd	35.537	31	41	41.4	6.7e-9	2.4e-11	9	42009.4	HUMAN	Actin, aortic smooth muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	8	25.2	9.37	9.5e-17	1049.8024	3	-17	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=37	28	V20130429-03_FTMSms2hcd	59.435	259	286	17.2	1.2e-5	1.2e-8	4	42009.4	HUMAN	Actin, aortic smooth muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	8	25.2	9.37	9.5e-17	400.7728	2	3.8	RGILTLK	RGILTLK		7	V20130429-03_FTMSms2hcd	25.715	64	70	17.9	0.011	8.1e-5	10	42009.4	HUMAN	Actin, aortic smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	8	25.3	9.37	9.5e-17	790.9051	2	0.43	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@314;Oxidation@326	14	V20130429-03_FTMSms2hcd	23.331	314	327	51.3	9.5e-17	1.2e-19	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	8	25.3	9.37	9.5e-17	677.8158	2	0.72	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-03_FTMSms2hcd	12.470	52	63	45.5	1.6e-13	2.1e-16	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	8	25.3	9.37	9.5e-17	895.9503	2	0.78	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-03_FTMSms2hcd	48.047	240	255	50.5	2.0e-13	2.3e-16	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	8	25.3	9.37	9.5e-17	589.3124	2	3.6	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@326	11	V20130429-03_FTMSms2hcd	25.376	317	327	40.0	2.7e-10	4.1e-13	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	8	25.3	9.37	9.5e-17	507.7446	2	0.69	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@191	8	V20130429-03_FTMSms2hcd	38.030	185	192	25.1	1.1e-9	2.1e-12	7	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	8	25.3	9.37	9.5e-17	400.2404	3	0.95	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-03_FTMSms2hcd	35.537	30	40	41.4	6.7e-9	2.4e-11	9	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	8	25.3	9.37	9.5e-17	1049.8024	3	-17	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@270=37	28	V20130429-03_FTMSms2hcd	59.435	258	285	17.2	1.2e-5	1.2e-8	4	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	8	25.3	9.37	9.5e-17	400.7728	2	3.8	RGILTLK	RGILTLK		7	V20130429-03_FTMSms2hcd	25.715	63	69	17.9	0.011	8.1e-5	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-6]	2	Q6S8J3	POTEE_HUMAN	POTEE	5	7.3	7.58	2.0e-13	895.9503	2	0.78	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-03_FTMSms2hcd	48.047	939	954	50.5	2.0e-13	2.3e-16	10	121364.6	HUMAN	POTE ankyrin domain family member E
[2-6]	2	Q6S8J3	POTEE_HUMAN	POTEE	5	7.3	7.58	2.0e-13	400.2404	3	0.95	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-03_FTMSms2hcd	35.537	729	739	41.4	6.7e-9	2.4e-11	9	121364.6	HUMAN	POTE ankyrin domain family member E
[2-6]	2	Q6S8J3	POTEE_HUMAN	POTEE	5	7.3	7.58	2.0e-13	656.6862	3	-18	VAPEEHPILLTEAPLNPK	VAPEEHPILLTEAPLNPK		18	V20130429-03_FTMSms2hcd	41.329	796	813	19.9	4.7e-7	9.2e-10	4	121364.6	HUMAN	POTE ankyrin domain family member E
[2-6]	2	Q6S8J3	POTEE_HUMAN	POTEE	5	7.3	7.58	2.0e-13	695.9300	5	6.4	YPMEHGIITNWDDMEKIWHHTFYNELR	YPMEHGIITNWDDMEKIWHHTFYNELR		27	V20130429-03_FTMSms2hcd	54.022	769	795	22.6	1.1e-6	1.0e-9	5	121364.6	HUMAN	POTE ankyrin domain family member E
[2-6]	2	Q6S8J3	POTEE_HUMAN	POTEE	5	7.3	7.58	2.0e-13	400.7728	2	3.8	RGILTLK	RGILTLK		7	V20130429-03_FTMSms2hcd	25.715	762	768	17.9	0.011	8.1e-5	10	121364.6	HUMAN	POTE ankyrin domain family member E
[2-7]	1	A5A3E0	POTEF_HUMAN	POTEF	4	5.7	7.58	2.0e-13	895.9503	2	0.78	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-03_FTMSms2hcd	48.047	939	954	50.5	2.0e-13	2.3e-16	10	121445.7	HUMAN	POTE ankyrin domain family member F
[2-7]	1	A5A3E0	POTEF_HUMAN	POTEF	4	5.7	7.58	2.0e-13	400.2404	3	0.95	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-03_FTMSms2hcd	35.537	729	739	41.4	6.7e-9	2.4e-11	9	121445.7	HUMAN	POTE ankyrin domain family member F
[2-7]	1	A5A3E0	POTEF_HUMAN	POTEF	4	5.7	7.58	2.0e-13	695.9300	5	6.4	YPMEHGIITNWDDMEKIWHHTFYNELR	YPMEHGIITNWDDMEKIWHHTFYNELR		27	V20130429-03_FTMSms2hcd	54.022	769	795	22.6	1.1e-6	1.0e-9	5	121445.7	HUMAN	POTE ankyrin domain family member F
[2-7]	1	A5A3E0	POTEF_HUMAN	POTEF	4	5.7	7.58	2.0e-13	400.7728	2	3.8	RGILTLK	RGILTLK		7	V20130429-03_FTMSms2hcd	25.715	762	768	17.9	0.011	8.1e-5	10	121445.7	HUMAN	POTE ankyrin domain family member F
[2-8]	2	Q9BYX7	ACTBM_HUMAN	POTEKP	3	16.3	7.58	2.0e-13	895.9503	2	0.78	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-03_FTMSms2hcd	48.047	239	254	50.5	2.0e-13	2.3e-16	10	42016.6	HUMAN	Putative beta-actin-like protein 3
[2-8]	2	Q9BYX7	ACTBM_HUMAN	POTEKP	3	16.3	7.58	2.0e-13	656.6862	3	-18	VAPEEHPILLTEAPLNPK	VAPEEHPILLTEAPLNPK		18	V20130429-03_FTMSms2hcd	41.329	96	113	19.9	4.7e-7	9.2e-10	4	42016.6	HUMAN	Putative beta-actin-like protein 3
[2-8]	2	Q9BYX7	ACTBM_HUMAN	POTEKP	3	16.3	7.58	2.0e-13	695.9300	5	6.4	YPMEHGIITNWDDMEKIWHHTFYNELR	YPMEHGIITNWDDMEKIWHHTFYNELR		27	V20130429-03_FTMSms2hcd	54.022	69	95	22.6	1.1e-6	1.0e-9	5	42016.6	HUMAN	Putative beta-actin-like protein 3
[2-9]	2	P0CG38	POTEI_HUMAN	POTEI	4	5.9	5.13	6.7e-9	400.2404	3	0.95	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-03_FTMSms2hcd	35.537	729	739	41.4	6.7e-9	2.4e-11	9	121283.5	HUMAN	POTE ankyrin domain family member I
[2-9]	2	P0CG38	POTEI_HUMAN	POTEI	4	5.9	5.13	6.7e-9	656.6862	3	-18	VAPEEHPILLTEAPLNPK	VAPEEHPILLTEAPLNPK		18	V20130429-03_FTMSms2hcd	41.329	796	813	19.9	4.7e-7	9.2e-10	4	121283.5	HUMAN	POTE ankyrin domain family member I
[2-9]	2	P0CG38	POTEI_HUMAN	POTEI	4	5.9	5.13	6.7e-9	695.9300	5	6.4	YPMEHGIITNWDDMEKIWHHTFYNELR	YPMEHGIITNWDDMEKIWHHTFYNELR		27	V20130429-03_FTMSms2hcd	54.022	769	795	22.6	1.1e-6	1.0e-9	5	121283.5	HUMAN	POTE ankyrin domain family member I
[2-9]	2	P0CG38	POTEI_HUMAN	POTEI	4	5.9	5.13	6.7e-9	400.7728	2	3.8	RGILTLK	RGILTLK		7	V20130429-03_FTMSms2hcd	25.715	762	768	17.9	0.011	8.1e-5	10	121283.5	HUMAN	POTE ankyrin domain family member I
[2-10]	0	Q562R1	ACTBL_HUMAN	ACTBL2	2	6.4	7.58	2.0e-13	895.9503	2	0.78	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-03_FTMSms2hcd	48.047	240	255	50.5	2.0e-13	2.3e-16	10	42003.6	HUMAN	Beta-actin-like protein 2
[2-10]	0	Q562R1	ACTBL_HUMAN	ACTBL2	2	6.4	7.58	2.0e-13	507.7446	2	0.69	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@191	8	V20130429-03_FTMSms2hcd	38.030	185	192	25.1	1.1e-9	2.1e-12	7	42003.6	HUMAN	Beta-actin-like protein 2
[2-11]	2	P0CG39	POTEJ_HUMAN	POTEJ	3	5.0	2.40	4.7e-7	656.6862	3	-18	VAPEEHPILLTEAPLNPK	VAPEEHPILLTEAPLNPK		18	V20130429-03_FTMSms2hcd	41.329	759	776	19.9	4.7e-7	9.2e-10	4	117391.0	HUMAN	POTE ankyrin domain family member J
[2-11]	2	P0CG39	POTEJ_HUMAN	POTEJ	3	5.0	2.40	4.7e-7	695.9300	5	6.4	YPMEHGIITNWDDMEKIWHHTFYNELR	YPMEHGIITNWDDMEKIWHHTFYNELR		27	V20130429-03_FTMSms2hcd	54.022	732	758	22.6	1.1e-6	1.0e-9	5	117391.0	HUMAN	POTE ankyrin domain family member J
[2-11]	2	P0CG39	POTEJ_HUMAN	POTEJ	3	5.0	2.40	4.7e-7	400.7728	2	3.8	RGILTLK	RGILTLK		7	V20130429-03_FTMSms2hcd	25.715	725	731	17.9	0.011	8.1e-5	10	117391.0	HUMAN	POTE ankyrin domain family member J
[3]		P06733	ENOA_HUMAN	ENO1	11	47.7	9.03	4.1e-16	1148.5787	2	5.4	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-03_FTMSms2hcd	77.774	373	394	40.4	4.1e-16	5.1e-19	3	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	11	47.7	9.03	4.1e-16	634.3247	4	-3.0	AAVPSGASTGIYEALELRDNDKTR	AAVPSGASTGIYEALELRDNDKTR		24	V20130429-03_FTMSms2hcd	43.708	33	56	45.8	3.1e-15	4.1e-18	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	11	47.7	9.03	4.1e-16	970.4936	2	1.6	LAMQEFMILPVGAANFR	LAM(Oxidation)QEFM(Oxidation)ILPVGAANFR	Oxidation@165;Oxidation@169	17	V20130429-03_FTMSms2hcd	56.809	163	179	51.6	1.4e-14	1.7e-17	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	11	47.7	9.03	4.1e-16	726.0303	3	0.93	AGYTDKVVIGMDVAASEFFR	AGYTDKVVIGMDVAASEFFR		20	V20130429-03_FTMSms2hcd	64.562	234	253	42.6	6.5e-14	6.8e-17	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	11	47.7	9.03	4.1e-16	995.8029	3	0.0055	SFIKDYPVVSIEDPFDQDDWGAWQK	SFIKDYPVVSIEDPFDQDDWGAWQK		25	V20130429-03_FTMSms2hcd	65.627	282	306	45.0	3.4e-13	3.3e-16	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	11	47.7	9.03	4.1e-16	915.1298	3	-1.3	DATNVGDEGGFAPNILENKEGLELLK	DATNVGDEGGFAPNILENKEGLELLK		26	V20130429-03_FTMSms2hcd	58.630	203	228	41.6	3.8e-11	4.8e-14	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	11	47.7	9.03	4.1e-16	731.9078	2	-0.22	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-03_FTMSms2hcd	60.425	106	120	31.1	1.2e-10	2.9e-13	3	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	11	47.7	9.03	4.1e-16	753.6503	4	3.2	HIADLAGNSEVILPVPAFNVINGGSHAGNK	HIADLAGNSEVILPVPAFNVINGGSHAGNK		30	V20130429-03_FTMSms2hcd	58.751	133	162	28.4	3.3e-9	6.7e-12	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	11	47.7	9.03	4.1e-16	713.3680	2	1.9	YISPDQLADLYK	YISPDQLADLYK		12	V20130429-03_FTMSms2hcd	49.033	270	281	33.2	7.5e-9	1.1e-11	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	11	47.7	9.03	4.1e-16	572.3113	2	-0.32	IGAEVYHNLK	IGAEVYHNLK		10	V20130429-03_FTMSms2hcd	23.231	184	193	40.9	1.4e-5	2.3e-8	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	11	47.7	9.03	4.1e-16	403.7301	2	1.3	YNQLLR	YNQLLR		6	V20130429-03_FTMSms2hcd	21.514	407	412	24.4	0.0065	1.5e-5	1	47169.4	HUMAN	Alpha-enolase
[3-1]	0	P09104	ENOG_HUMAN	ENO2	2	8.5	9.03	4.1e-16	1148.5787	2	5.4	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-03_FTMSms2hcd	77.774	373	394	40.4	4.1e-16	5.1e-19	3	47269.0	HUMAN	Gamma-enolase
[3-1]	0	P09104	ENOG_HUMAN	ENO2	2	8.5	9.03	4.1e-16	731.9078	2	-0.22	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-03_FTMSms2hcd	60.425	106	120	31.1	1.2e-10	2.9e-13	3	47269.0	HUMAN	Gamma-enolase
[3-2]	0	P13929	ENOB_HUMAN	ENO3	2	8.5	9.03	4.1e-16	1148.5787	2	5.4	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-03_FTMSms2hcd	77.774	373	394	40.4	4.1e-16	5.1e-19	3	46932.2	HUMAN	Beta-enolase
[3-2]	0	P13929	ENOB_HUMAN	ENO3	2	8.5	9.03	4.1e-16	731.9078	2	-0.22	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-03_FTMSms2hcd	60.425	106	120	31.1	1.2e-10	2.9e-13	3	46932.2	HUMAN	Beta-enolase
[4]		P08670	VIME_HUMAN	VIM	11	35.6	10.72	3.0e-19	981.5128	4	3.8	LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR	LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR		34	V20130429-03_FTMSms2hcd	57.695	237	270	50.1	3.0e-19	8.0e-22	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	11	35.6	10.72	3.0e-19	918.9042	2	0.90	DGQVINETSQHHDDLE	DGQVINETSQHHDDLE		16	V20130429-03_FTMSms2hcd	22.802	451	466	30.5	8.3e-14	1.1e-16	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	11	35.6	10.72	3.0e-19	785.9533	2	2.7	ISLPLPNFSSLNLR	ISLPLPNFSSLNLR		14	V20130429-03_FTMSms2hcd	65.787	411	424	44.2	5.8e-11	2.2e-13	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	11	35.6	10.72	3.0e-19	592.9595	3	0.90	FADLSEAANRNNDALR	FADLSEAANRNNDALR		16	V20130429-03_FTMSms2hcd	30.757	295	310	32.9	7.4e-11	8.1e-14	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	11	35.6	10.72	3.0e-19	883.9066	2	0.66	LQDEIQNMKEEMAR	LQDEIQNM(Oxidation)KEEM(Oxidation)AR	Oxidation@372;Oxidation@376	14	V20130429-03_FTMSms2hcd	16.953	365	378	34.7	7.8e-10	8.8e-13	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	11	35.6	10.72	3.0e-19	748.3937	2	-4.2	TYSLGSALRPSTSR	TYSLGSALRPSTSR		14	V20130429-03_FTMSms2hcd	30.744	37	50	39.8	1.6e-9	2.4e-12	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	11	35.6	10.72	3.0e-19	554.6542	3	0.48	KVESLQEEIAFLKK	KVESLQEEIAFLKK		14	V20130429-03_FTMSms2hcd	43.182	223	236	41.6	3.3e-9	1.6e-11	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	11	35.6	10.72	3.0e-19	794.4052	2	3.7	TNEKVELQELNDR	TNEKVELQELNDR		13	V20130429-03_FTMSms2hcd	26.938	101	113	53.6	5.3e-9	6.6e-12	2	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	11	35.6	10.72	3.0e-19	513.9760	3	1.9	ILLAELEQLKGQGK	ILLAELEQLKGQGK		14	V20130429-03_FTMSms2hcd	45.796	130	143	52.8	8.1e-9	6.3e-11	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	11	35.6	10.72	3.0e-19	561.2968	2	2.3	EYQDLLNVK	EYQDLLNVK		9	V20130429-03_FTMSms2hcd	37.029	382	390	22.1	3.8e-7	6.3e-10	6	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	11	35.6	10.72	3.0e-19	457.7324	2	-0.29	SYVTTSTR	SYVTTSTR		8	V20130429-03_FTMSms2hcd	12.324	29	36	30.3	2.6e-6	5.4e-9	1	53652.1	HUMAN	Vimentin
[4-1]	0	P17661	DESM_HUMAN	DES	2	4.7	5.19	5.3e-9	794.4052	2	3.7	TNEKVELQELNDR	TNEKVELQELNDR		13	V20130429-03_FTMSms2hcd	26.938	106	118	53.6	5.3e-9	6.6e-12	2	53536.2	HUMAN	Desmin
[4-1]	0	P17661	DESM_HUMAN	DES	2	4.7	5.19	5.3e-9	561.2968	2	2.3	EYQDLLNVK	EYQDLLNVK		9	V20130429-03_FTMSms2hcd	37.029	387	395	22.1	3.8e-7	6.3e-10	6	53536.2	HUMAN	Desmin
[4-2]	0	P07196	NFL_HUMAN	NEFL	1	1.7	2.40	3.8e-7	561.2968	2	2.3	EYQDLLNVK	EYQDLLNVK		9	V20130429-03_FTMSms2hcd	37.029	371	379	22.1	3.8e-7	6.3e-10	6	61517.1	HUMAN	Neurofilament light polypeptide
[4-3]	0	P07197	NFM_HUMAN	NEFM	1	1.0	2.40	3.8e-7	561.2968	2	2.3	EYQDLLNVK	EYQDLLNVK		9	V20130429-03_FTMSms2hcd	37.029	383	391	22.1	3.8e-7	6.3e-10	6	102472.8	HUMAN	Neurofilament medium polypeptide
[4-4]	0	P12036	NFH_HUMAN	NEFH	1	0.9	2.40	3.8e-7	561.2968	2	2.3	EYQDLLNVK	EYQDLLNVK		9	V20130429-03_FTMSms2hcd	37.029	384	392	22.1	3.8e-7	6.3e-10	6	112479.8	HUMAN	Neurofilament heavy polypeptide
[4-5]	0	Q16352	AINX_HUMAN	INA	1	1.8	2.40	3.8e-7	561.2968	2	2.3	EYQDLLNVK	EYQDLLNVK		9	V20130429-03_FTMSms2hcd	37.029	378	386	22.1	3.8e-7	6.3e-10	6	55391.1	HUMAN	Alpha-internexin
[5]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	8.89	7.3e-16	813.9070	2	1.5	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-03_FTMSms2hcd	21.850	38	51	54.1	7.3e-16	8.7e-19	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[5]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	8.89	7.3e-16	794.9448	2	1.1	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-03_FTMSms2hcd	34.605	6	20	46.9	6.6e-15	1.5e-17	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[5]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	8.89	7.3e-16	673.3718	4	1.1	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-03_FTMSms2hcd	38.244	6	30	37.8	1.1e-13	4.5e-16	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[5]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	8.89	7.3e-16	844.4670	3	3.0	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-03_FTMSms2hcd	51.547	267	290	42.4	3.2e-13	1.3e-15	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[5]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	8.89	7.3e-16	1013.0530	4	4.0	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		37	V20130429-03_FTMSms2hcd	70.374	219	255	42.2	3.4e-13	2.2e-15	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[5]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	8.89	7.3e-16	981.0300	4	4.9	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		36	V20130429-03_FTMSms2hcd	74.438	220	255	37.5	3.4e-12	1.6e-14	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[5]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	8.89	7.3e-16	560.8041	2	1.1	STTTGHLIYK	STTTGHLIYK		10	V20130429-03_FTMSms2hcd	18.241	21	30	36.6	4.8e-8	8.8e-11	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[5]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	8.89	7.3e-16	513.3091	2	0.70	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-03_FTMSms2hcd	31.514	256	266	46.2	2.6e-7	1.9e-9	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[5]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	8.89	7.3e-16	457.7885	2	3.0	QTVAVGVIK	QTVAVGVIK		9	V20130429-03_FTMSms2hcd	26.762	431	439	31.3	7.9e-6	2.4e-8	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[5-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	8.89	7.3e-16	813.9070	2	1.5	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-03_FTMSms2hcd	21.850	38	51	54.1	7.3e-16	8.7e-19	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[5-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	8.89	7.3e-16	794.9448	2	1.1	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-03_FTMSms2hcd	34.605	6	20	46.9	6.6e-15	1.5e-17	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[5-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	8.89	7.3e-16	673.3718	4	1.1	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-03_FTMSms2hcd	38.244	6	30	37.8	1.1e-13	4.5e-16	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[5-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	8.89	7.3e-16	844.4670	3	3.0	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-03_FTMSms2hcd	51.547	267	290	42.4	3.2e-13	1.3e-15	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[5-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	8.89	7.3e-16	1013.0530	4	4.0	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		37	V20130429-03_FTMSms2hcd	70.374	219	255	42.2	3.4e-13	2.2e-15	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[5-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	8.89	7.3e-16	981.0300	4	4.9	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		36	V20130429-03_FTMSms2hcd	74.438	220	255	37.5	3.4e-12	1.6e-14	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[5-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	8.89	7.3e-16	560.8041	2	1.1	STTTGHLIYK	STTTGHLIYK		10	V20130429-03_FTMSms2hcd	18.241	21	30	36.6	4.8e-8	8.8e-11	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[5-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	8.89	7.3e-16	513.3091	2	0.70	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-03_FTMSms2hcd	31.514	256	266	46.2	2.6e-7	1.9e-9	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[5-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	8.89	7.3e-16	457.7885	2	3.0	QTVAVGVIK	QTVAVGVIK		9	V20130429-03_FTMSms2hcd	26.762	431	439	31.3	7.9e-6	2.4e-8	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[5-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	6	12.7	8.89	7.3e-16	813.9070	2	1.5	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-03_FTMSms2hcd	21.850	38	51	54.1	7.3e-16	8.7e-19	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[5-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	6	12.7	8.89	7.3e-16	794.9448	2	1.1	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-03_FTMSms2hcd	34.605	6	20	46.9	6.6e-15	1.5e-17	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[5-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	6	12.7	8.89	7.3e-16	673.3718	4	1.1	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-03_FTMSms2hcd	38.244	6	30	37.8	1.1e-13	4.5e-16	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[5-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	6	12.7	8.89	7.3e-16	560.8041	2	1.1	STTTGHLIYK	STTTGHLIYK		10	V20130429-03_FTMSms2hcd	18.241	21	30	36.6	4.8e-8	8.8e-11	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[5-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	6	12.7	8.89	7.3e-16	513.3091	2	0.70	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-03_FTMSms2hcd	31.514	256	266	46.2	2.6e-7	1.9e-9	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[5-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	6	12.7	8.89	7.3e-16	457.7885	2	3.0	QTVAVGVIK	QTVAVGVIK		9	V20130429-03_FTMSms2hcd	26.762	431	439	31.3	7.9e-6	2.4e-8	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[6]		P14618	KPYM_HUMAN	PKM2	10	31.6	8.92	6.5e-16	1006.5368	3	0.54	TATESFASDPILYRPVAVALDTKGPEIR	TATESFASDPILYRPVAVALDTKGPEIR		28	V20130429-03_FTMSms2hcd	56.756	93	120	48.0	6.5e-16	1.6e-18	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	31.6	8.92	6.5e-16	1088.0629	2	0.26	LAPITSDPTEATAVGAVEASFK	LAPITSDPTEATAVGAVEASFK		22	V20130429-03_FTMSms2hcd	55.573	401	422	51.9	1.5e-13	1.9e-16	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	31.6	8.92	6.5e-16	696.7006	3	-0.0084	EAEAAIYHLQLFEELRR	EAEAAIYHLQLFEELRR		17	V20130429-03_FTMSms2hcd	53.754	384	400	56.7	3.8e-12	6.0e-15	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	31.6	8.92	6.5e-16	883.4121	4	0.45	MSKPHSEAGTAFIQTQQLHAAMADTFLEHMCR	M(Met-loss+Acetyl)SKPHSEAGTAFIQTQQLHAAM(Oxidation)ADTFLEHM(Oxidation)CR	Met-loss+Acetyl@1;Oxidation@22;Oxidation@30	32	V20130429-03_FTMSms2hcd	45.581	1	32	39.7	1.4e-11	1.4e-14	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	31.6	8.92	6.5e-16	890.4451	2	3.9	GADFLVTEVENGGSLGSK	GADFLVTEVENGGSLGSK		18	V20130429-03_FTMSms2hcd	49.516	189	206	33.6	1.3e-9	1.5e-12	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	31.6	8.92	6.5e-16	607.2938	2	2.8	ITLDNAYMEK	ITLDNAYM(Oxidation)EK	Oxidation@149	10	V20130429-03_FTMSms2hcd	27.360	142	151	41.6	1.4e-9	2.1e-12	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	31.6	8.92	6.5e-16	599.3281	2	1.3	LDIDSPPITAR	LDIDSPPITAR		11	V20130429-03_FTMSms2hcd	36.131	33	43	41.2	9.1e-9	2.1e-11	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	31.6	8.92	6.5e-16	668.6682	3	0.26	FGVEQDVDMVFASFIRK	FGVEQDVDM(Oxidation)VFASFIRK	Oxidation@239	17	V20130429-03_FTMSms2hcd	68.054	231	247	16.3	1.7e-6	1.9e-9	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	31.6	8.92	6.5e-16	625.9694	3	-0.49	FGVEQDVDMVFASFIR	FGVEQDVDM(Oxidation)VFASFIR	Oxidation@239	16	V20130429-03_FTMSms2hcd	73.972	231	246	13.1	4.4e-5	4.7e-8	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	31.6	8.92	6.5e-16	651.8400	2	-8.2	NTGIICTIGPASR	NTGIICTIGPASR		13	V20130429-03_FTMSms2hcd	37.084	44	56	17.1	0.0014	2.0e-6	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	15.1	9.08	3.4e-16	996.8507	3	2.1	DLVVLLFETALLSSGFSLEDPQTHSNR	DLVVLLFETALLSSGFSLEDPQTHSNR		27	V20130429-03_FTMSms2hcd	77.894	653	679	40.9	3.4e-16	6.0e-19	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	15.1	9.08	3.4e-16	649.2685	3	-0.036	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@255=42	17	V20130429-03_FTMSms2hcd	12.851	250	266	48.6	4.6e-15	7.3e-18	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	15.1	9.08	3.4e-16	594.9877	3	-0.65	HLEINPDHPIVETLR	HLEINPDHPIVETLR		15	V20130429-03_FTMSms2hcd	38.525	625	639	38.3	3.0e-14	5.1e-17	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	15.1	9.08	3.4e-16	683.3700	2	2.4	TLTLVDTGIGMTK	TLTLVDTGIGM(Oxidation)TK	Oxidation@93	13	V20130429-03_FTMSms2hcd	39.646	83	95	52.4	8.4e-14	1.4e-16	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	15.1	9.08	3.4e-16	757.3960	2	-0.62	GVVDSEDLPLNISR	GVVDSEDLPLNISR		14	V20130429-03_FTMSms2hcd	44.710	379	392	44.0	6.8e-12	1.0e-14	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	15.1	9.08	3.4e-16	478.5161	4	-1.1	KHLEINPDHPIVETLR	KHLEINPDHPIVETLR		16	V20130429-03_FTMSms2hcd	33.692	624	639	22.1	3.3e-9	9.7e-12	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	15.1	9.08	3.4e-16	576.2822	2	-0.67	YIDQEELNK	YIDQEELNK		9	V20130429-03_FTMSms2hcd	21.094	276	284	22.9	2.9e-7	4.3e-10	4	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	15.1	9.08	3.4e-16	415.2683	2	-0.14	ALLFIPR	ALLFIPR		7	V20130429-03_FTMSms2hcd	46.386	331	337	19.5	6.9e-5	2.5e-7	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	15.1	9.08	3.4e-16	365.7274	2	2.4	LSELLR	LSELLR		6	V20130429-03_FTMSms2hcd	26.482	451	456	21.0	0.018	3.6e-5	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7-1]	0	P07900	HS90A_HUMAN	HSP90AA1	4	5.7	7.78	8.4e-14	683.3700	2	2.4	TLTIVDTGIGMTK	TLTIVDTGIGM(Oxidation)TK	Oxidation@98	13	V20130429-03_FTMSms2hcd	39.646	88	100	52.4	8.4e-14	1.4e-16	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[7-1]	0	P07900	HS90A_HUMAN	HSP90AA1	4	5.7	7.78	8.4e-14	757.3960	2	-0.62	GVVDSEDLPLNISR	GVVDSEDLPLNISR		14	V20130429-03_FTMSms2hcd	44.710	387	400	44.0	6.8e-12	1.0e-14	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[7-1]	0	P07900	HS90A_HUMAN	HSP90AA1	4	5.7	7.78	8.4e-14	576.2822	2	-0.67	YIDQEELNK	YIDQEELNK		9	V20130429-03_FTMSms2hcd	21.094	284	292	22.9	2.9e-7	4.3e-10	4	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[7-1]	0	P07900	HS90A_HUMAN	HSP90AA1	4	5.7	7.78	8.4e-14	365.7274	2	2.4	LSELLR	LSELLR		6	V20130429-03_FTMSms2hcd	26.482	459	464	21.0	0.018	3.6e-5	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[7-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	2	6.8	8.46	4.6e-15	649.2685	3	-0.036	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@177=42	17	V20130429-03_FTMSms2hcd	12.851	172	188	48.6	4.6e-15	7.3e-18	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[7-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	2	6.8	8.46	4.6e-15	576.2822	2	-0.67	YIDQEELNK	YIDQEELNK		9	V20130429-03_FTMSms2hcd	21.094	198	206	22.9	2.9e-7	4.3e-10	4	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[7-3]	0	Q58FG1	HS904_HUMAN	HSP90AA4P	1	3.1	7.78	8.4e-14	683.3700	2	2.4	TLTIVDTGIGMTK	TLTIVDTGIGM(Oxidation)TK	Oxidation@38	13	V20130429-03_FTMSms2hcd	39.646	28	40	52.4	8.4e-14	1.4e-16	3	47712.3	HUMAN	Putative heat shock protein HSP 90-alpha A4
[7-4]	0	Q12931	TRAP1_HUMAN	TRAP1	1	2.0	6.75	6.8e-12	757.3960	2	-0.62	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR		14	V20130429-03_FTMSms2hcd	44.710	389	402	44.0	6.8e-12	1.0e-14	3	80110.7	HUMAN	Heat shock protein 75 kDa, mitochondrial
[7-5]	0	Q14568	HS902_HUMAN	HSP90AA2	1	2.6	2.54	2.9e-7	576.2822	2	-0.67	YIDQEELNK	YIDQEELNK		9	V20130429-03_FTMSms2hcd	21.094	283	291	22.9	2.9e-7	4.3e-10	4	39365.1	HUMAN	Putative heat shock protein HSP 90-alpha A2
[8]		P07437	TBB5_HUMAN	TUBB	9	31.8	8.14	1.8e-14	681.3699	3	10	MAVTFIGNSTAIQELFKR	M(Oxidation)AVTFIGNSTAIQELFKR	Oxidation@363	18	V20130429-03_FTMSms2hcd	59.154	363	380	49.0	1.8e-14	4.1e-17	1	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	9	31.8	8.14	1.8e-14	696.3632	3	-0.82	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-03_FTMSms2hcd	58.350	104	122	38.2	3.7e-12	4.9e-15	5	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	9	31.8	8.14	1.8e-14	818.9204	2	1.9	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-03_FTMSms2hcd	51.991	263	276	40.5	1.0e-10	1.3e-13	9	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	9	31.8	8.14	1.8e-14	830.4517	2	0.55	ALTVPELTQQVFDAK	ALTVPELTQQVFDAK		15	V20130429-03_FTMSms2hcd	57.130	283	297	48.1	1.8e-10	3.7e-13	1	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	9	31.8	8.14	1.8e-14	668.3521	2	-0.58	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-03_FTMSms2hcd	36.418	163	174	39.5	1.4e-9	2.3e-12	4	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	9	31.8	8.14	1.8e-14	580.3175	2	-1.3	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-03_FTMSms2hcd	41.209	253	262	36.0	1.1e-8	1.8e-11	11	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	9	31.8	8.14	1.8e-14	520.3005	2	0.22	YLTVAAVFR	YLTVAAVFR		9	V20130429-03_FTMSms2hcd	48.580	310	318	30.5	8.1e-8	3.5e-10	3	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	9	31.8	8.14	1.8e-14	539.2702	2	0.72	IREEYPDR	IREEYPDR		8	V20130429-03_FTMSms2hcd	12.920	155	162	37.5	3.9e-6	6.5e-9	8	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	9	31.8	8.14	1.8e-14	782.2034	5	0.98	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-03_FTMSms2hcd	69.882	217	252	18.8	1.7e-5	3.6e-8	5	49671.3	HUMAN	Tubulin beta chain
[8-1]	0	P68371	TBB4B_HUMAN	TUBB4B	7	24.3	6.89	3.7e-12	696.3632	3	-0.82	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-03_FTMSms2hcd	58.350	104	122	38.2	3.7e-12	4.9e-15	5	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	0	P68371	TBB4B_HUMAN	TUBB4B	7	24.3	6.89	3.7e-12	818.9204	2	1.9	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-03_FTMSms2hcd	51.991	263	276	40.5	1.0e-10	1.3e-13	9	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	0	P68371	TBB4B_HUMAN	TUBB4B	7	24.3	6.89	3.7e-12	668.3521	2	-0.58	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-03_FTMSms2hcd	36.418	163	174	39.5	1.4e-9	2.3e-12	4	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	0	P68371	TBB4B_HUMAN	TUBB4B	7	24.3	6.89	3.7e-12	580.3175	2	-1.3	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-03_FTMSms2hcd	41.209	253	262	36.0	1.1e-8	1.8e-11	11	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	0	P68371	TBB4B_HUMAN	TUBB4B	7	24.3	6.89	3.7e-12	520.3005	2	0.22	YLTVAAVFR	YLTVAAVFR		9	V20130429-03_FTMSms2hcd	48.580	310	318	30.5	8.1e-8	3.5e-10	3	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	0	P68371	TBB4B_HUMAN	TUBB4B	7	24.3	6.89	3.7e-12	539.2702	2	0.72	IREEYPDR	IREEYPDR		8	V20130429-03_FTMSms2hcd	12.920	155	162	37.5	3.9e-6	6.5e-9	8	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	0	P68371	TBB4B_HUMAN	TUBB4B	7	24.3	6.89	3.7e-12	782.2034	5	0.98	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-03_FTMSms2hcd	69.882	217	252	18.8	1.7e-5	3.6e-8	5	49831.5	HUMAN	Tubulin beta-4B chain
[8-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	5	19.6	6.89	3.7e-12	696.3632	3	-0.82	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-03_FTMSms2hcd	58.350	104	122	38.2	3.7e-12	4.9e-15	5	49907.4	HUMAN	Tubulin beta-2A chain
[8-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	5	19.6	6.89	3.7e-12	818.9204	2	1.9	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-03_FTMSms2hcd	51.991	263	276	40.5	1.0e-10	1.3e-13	9	49907.4	HUMAN	Tubulin beta-2A chain
[8-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	5	19.6	6.89	3.7e-12	580.3175	2	-1.3	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-03_FTMSms2hcd	41.209	253	262	36.0	1.1e-8	1.8e-11	11	49907.4	HUMAN	Tubulin beta-2A chain
[8-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	5	19.6	6.89	3.7e-12	539.2702	2	0.72	IREEYPDR	IREEYPDR		8	V20130429-03_FTMSms2hcd	12.920	155	162	37.5	3.9e-6	6.5e-9	8	49907.4	HUMAN	Tubulin beta-2A chain
[8-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	5	19.6	6.89	3.7e-12	782.2034	5	0.98	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-03_FTMSms2hcd	69.882	217	252	18.8	1.7e-5	3.6e-8	5	49907.4	HUMAN	Tubulin beta-2A chain
[8-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	5	19.6	6.89	3.7e-12	696.3632	3	-0.82	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-03_FTMSms2hcd	58.350	104	122	38.2	3.7e-12	4.9e-15	5	49953.5	HUMAN	Tubulin beta-2B chain
[8-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	5	19.6	6.89	3.7e-12	818.9204	2	1.9	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-03_FTMSms2hcd	51.991	263	276	40.5	1.0e-10	1.3e-13	9	49953.5	HUMAN	Tubulin beta-2B chain
[8-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	5	19.6	6.89	3.7e-12	580.3175	2	-1.3	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-03_FTMSms2hcd	41.209	253	262	36.0	1.1e-8	1.8e-11	11	49953.5	HUMAN	Tubulin beta-2B chain
[8-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	5	19.6	6.89	3.7e-12	539.2702	2	0.72	IREEYPDR	IREEYPDR		8	V20130429-03_FTMSms2hcd	12.920	155	162	37.5	3.9e-6	6.5e-9	8	49953.5	HUMAN	Tubulin beta-2B chain
[8-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	5	19.6	6.89	3.7e-12	782.2034	5	0.98	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-03_FTMSms2hcd	69.882	217	252	18.8	1.7e-5	3.6e-8	5	49953.5	HUMAN	Tubulin beta-2B chain
[8-4]	0	P04350	TBB4A_HUMAN	TUBB4A	5	18.2	6.11	1.0e-10	818.9204	2	1.9	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-03_FTMSms2hcd	51.991	263	276	40.5	1.0e-10	1.3e-13	9	49586.2	HUMAN	Tubulin beta-4A chain
[8-4]	0	P04350	TBB4A_HUMAN	TUBB4A	5	18.2	6.11	1.0e-10	668.3521	2	-0.58	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-03_FTMSms2hcd	36.418	163	174	39.5	1.4e-9	2.3e-12	4	49586.2	HUMAN	Tubulin beta-4A chain
[8-4]	0	P04350	TBB4A_HUMAN	TUBB4A	5	18.2	6.11	1.0e-10	580.3175	2	-1.3	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-03_FTMSms2hcd	41.209	253	262	36.0	1.1e-8	1.8e-11	11	49586.2	HUMAN	Tubulin beta-4A chain
[8-4]	0	P04350	TBB4A_HUMAN	TUBB4A	5	18.2	6.11	1.0e-10	520.3005	2	0.22	YLTVAAVFR	YLTVAAVFR		9	V20130429-03_FTMSms2hcd	48.580	310	318	30.5	8.1e-8	3.5e-10	3	49586.2	HUMAN	Tubulin beta-4A chain
[8-4]	0	P04350	TBB4A_HUMAN	TUBB4A	5	18.2	6.11	1.0e-10	782.2034	5	0.98	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-03_FTMSms2hcd	69.882	217	252	18.8	1.7e-5	3.6e-8	5	49586.2	HUMAN	Tubulin beta-4A chain
[8-5]	0	Q13509	TBB3_HUMAN	TUBB3	3	9.1	6.84	3.7e-12	696.3632	3	-0.82	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-03_FTMSms2hcd	58.350	104	122	38.2	3.7e-12	4.9e-15	5	50433.2	HUMAN	Tubulin beta-3 chain
[8-5]	0	Q13509	TBB3_HUMAN	TUBB3	3	9.1	6.84	3.7e-12	668.3521	2	-0.58	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-03_FTMSms2hcd	36.418	163	174	39.5	1.4e-9	2.3e-12	4	50433.2	HUMAN	Tubulin beta-3 chain
[8-5]	0	Q13509	TBB3_HUMAN	TUBB3	3	9.1	6.84	3.7e-12	580.3175	2	-1.3	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-03_FTMSms2hcd	41.209	253	262	36.0	1.1e-8	1.8e-11	11	50433.2	HUMAN	Tubulin beta-3 chain
[8-6]	0	Q3ZCM7	TBB8_HUMAN	TUBB8	3	7.2	6.11	1.0e-10	818.9204	2	1.9	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-03_FTMSms2hcd	51.991	263	276	40.5	1.0e-10	1.3e-13	9	49776.5	HUMAN	Tubulin beta-8 chain
[8-6]	0	Q3ZCM7	TBB8_HUMAN	TUBB8	3	7.2	6.11	1.0e-10	580.3175	2	-1.3	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-03_FTMSms2hcd	41.209	253	262	36.0	1.1e-8	1.8e-11	11	49776.5	HUMAN	Tubulin beta-8 chain
[8-6]	0	Q3ZCM7	TBB8_HUMAN	TUBB8	3	7.2	6.11	1.0e-10	539.2702	2	0.72	IREEYPDR	IREEYPDR		8	V20130429-03_FTMSms2hcd	12.920	155	162	37.5	3.9e-6	6.5e-9	8	49776.5	HUMAN	Tubulin beta-8 chain
[8-7]	0	A6NKZ8	YI016_HUMAN		3	8.6	6.11	1.0e-10	818.9204	2	1.9	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@195	14	V20130429-03_FTMSms2hcd	51.991	191	204	40.5	1.0e-10	1.3e-13	9	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[8-7]	0	A6NKZ8	YI016_HUMAN		3	8.6	6.11	1.0e-10	580.3175	2	-1.3	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@185	10	V20130429-03_FTMSms2hcd	41.209	181	190	36.0	1.1e-8	1.8e-11	11	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[8-7]	0	A6NKZ8	YI016_HUMAN		3	8.6	6.11	1.0e-10	539.2702	2	0.72	IREEYPDR	IREEYPDR		8	V20130429-03_FTMSms2hcd	12.920	83	90	37.5	3.9e-6	6.5e-9	8	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[8-8]	0	A6NNZ2	TBB8B_HUMAN		3	7.2	6.11	1.0e-10	818.9204	2	1.9	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-03_FTMSms2hcd	51.991	263	276	40.5	1.0e-10	1.3e-13	9	49573.1	HUMAN	Tubulin beta-8 chain B
[8-8]	0	A6NNZ2	TBB8B_HUMAN		3	7.2	6.11	1.0e-10	580.3175	2	-1.3	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-03_FTMSms2hcd	41.209	253	262	36.0	1.1e-8	1.8e-11	11	49573.1	HUMAN	Tubulin beta-8 chain B
[8-8]	0	A6NNZ2	TBB8B_HUMAN		3	7.2	6.11	1.0e-10	539.2702	2	0.72	IREEYPDR	IREEYPDR		8	V20130429-03_FTMSms2hcd	12.920	155	162	37.5	3.9e-6	6.5e-9	8	49573.1	HUMAN	Tubulin beta-8 chain B
[8-9]	0	Q9BUF5	TBB6_HUMAN	TUBB6	2	5.4	6.11	1.0e-10	818.9204	2	1.9	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-03_FTMSms2hcd	51.991	263	276	40.5	1.0e-10	1.3e-13	9	49857.6	HUMAN	Tubulin beta-6 chain
[8-9]	0	Q9BUF5	TBB6_HUMAN	TUBB6	2	5.4	6.11	1.0e-10	580.3175	2	-1.3	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-03_FTMSms2hcd	41.209	253	262	36.0	1.1e-8	1.8e-11	11	49857.6	HUMAN	Tubulin beta-6 chain
[8-10]	0	Q9H4B7	TBB1_HUMAN	TUBB1	2	4.0	4.76	1.1e-8	580.3175	2	-1.3	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-03_FTMSms2hcd	41.209	253	262	36.0	1.1e-8	1.8e-11	11	50327.4	HUMAN	Tubulin beta-1 chain
[8-10]	0	Q9H4B7	TBB1_HUMAN	TUBB1	2	4.0	4.76	1.1e-8	539.2702	2	0.72	IREEYPDR	IREEYPDR		8	V20130429-03_FTMSms2hcd	12.920	155	162	37.5	3.9e-6	6.5e-9	8	50327.4	HUMAN	Tubulin beta-1 chain
[9]		P62805	H4_HUMAN	HIST1H4A	8	52.4	7.22	9.1e-13	741.9031	2	0.30	TVTAMDVVYALKR	TVTAM(Oxidation)DVVYALKR	Oxidation@85	13	V20130429-03_FTMSms2hcd	41.083	81	93	36.2	9.1e-13	2.0e-15	1	11367.4	HUMAN	Histone H4
[9]		P62805	H4_HUMAN	HIST1H4A	8	52.4	7.22	9.1e-13	702.3785	3	8.7	VFLENVIRDAVTYTEHAK	VFLENVIRDAVTYTEHAK		18	V20130429-03_FTMSms2hcd	63.221	61	78	41.5	1.1e-10	2.0e-13	1	11367.4	HUMAN	Histone H4
[9]		P62805	H4_HUMAN	HIST1H4A	8	52.4	7.22	9.1e-13	663.8515	2	-1.2	TVTAMDVVYALK	TVTAM(Oxidation)DVVYALK	Oxidation@85	12	V20130429-03_FTMSms2hcd	44.628	81	92	33.4	1.2e-10	2.2e-13	1	11367.4	HUMAN	Histone H4
[9]		P62805	H4_HUMAN	HIST1H4A	8	52.4	7.22	9.1e-13	567.7743	2	-1.1	DAVTYTEHAK	DAVTYTEHAK		10	V20130429-03_FTMSms2hcd	13.079	69	78	33.4	1.0e-9	1.6e-12	1	11367.4	HUMAN	Histone H4
[9]		P62805	H4_HUMAN	HIST1H4A	8	52.4	7.22	9.1e-13	590.8136	2	-0.77	ISGLIYEETR	ISGLIYEETR		10	V20130429-03_FTMSms2hcd	33.419	47	56	37.5	5.7e-8	8.4e-11	1	11367.4	HUMAN	Histone H4
[9]		P62805	H4_HUMAN	HIST1H4A	8	52.4	7.22	9.1e-13	495.2958	2	6.5	VFLENVIR	VFLENVIR		8	V20130429-03_FTMSms2hcd	43.917	61	68	34.5	7.5e-8	2.7e-10	1	11367.4	HUMAN	Histone H4
[9]		P62805	H4_HUMAN	HIST1H4A	8	52.4	7.22	9.1e-13	663.3821	2	2.5	DNIQGITKPAIR	DNIQGITKPAIR		12	V20130429-03_FTMSms2hcd	27.775	25	36	31.3	1.2e-7	4.4e-10	1	11367.4	HUMAN	Histone H4
[9]		P62805	H4_HUMAN	HIST1H4A	8	52.4	7.22	9.1e-13	741.4305	2	-0.65	DNIQGITKPAIRR	DNIQGITKPAIRR		13	V20130429-03_FTMSms2hcd	24.013	25	37	41.2	9.9e-7	5.0e-9	1	11367.4	HUMAN	Histone H4
[10]		P68363	TBA1B_HUMAN	TUBA1B	6	22.2	8.95	5.7e-16	800.0641	3	-0.36	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-03_FTMSms2hcd	49.300	85	105	47.6	5.7e-16	6.0e-19	6	50152.1	HUMAN	Tubulin alpha-1B chain
[10]		P68363	TBA1B_HUMAN	TUBA1B	6	22.2	8.95	5.7e-16	1004.4507	2	0.54	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-03_FTMSms2hcd	51.349	41	60	45.9	2.4e-13	2.7e-16	5	50152.1	HUMAN	Tubulin alpha-1B chain
[10]		P68363	TBA1B_HUMAN	TUBA1B	6	22.2	8.95	5.7e-16	744.4434	2	0.24	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-03_FTMSms2hcd	67.934	230	243	43.0	5.3e-11	3.0e-13	5	50152.1	HUMAN	Tubulin alpha-1B chain
[10]		P68363	TBA1B_HUMAN	TUBA1B	6	22.2	8.95	5.7e-16	851.4585	2	2.3	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-03_FTMSms2hcd	57.574	65	79	47.7	6.1e-11	1.1e-13	3	50152.1	HUMAN	Tubulin alpha-1B chain
[10]		P68363	TBA1B_HUMAN	TUBA1B	6	22.2	8.95	5.7e-16	573.6328	3	1.1	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-03_FTMSms2hcd	34.418	216	229	31.6	1.6e-6	2.0e-9	7	50152.1	HUMAN	Tubulin alpha-1B chain
[10]		P68363	TBA1B_HUMAN	TUBA1B	6	22.2	8.95	5.7e-16	586.3239	3	-3.5	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-03_FTMSms2hcd	52.618	265	280	16.9	3.7e-6	8.5e-9	6	50152.1	HUMAN	Tubulin alpha-1B chain
[10-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	6	22.3	8.95	5.7e-16	800.0641	3	-0.36	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-03_FTMSms2hcd	49.300	85	105	47.6	5.7e-16	6.0e-19	6	49895.8	HUMAN	Tubulin alpha-1C chain
[10-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	6	22.3	8.95	5.7e-16	1004.4507	2	0.54	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-03_FTMSms2hcd	51.349	41	60	45.9	2.4e-13	2.7e-16	5	49895.8	HUMAN	Tubulin alpha-1C chain
[10-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	6	22.3	8.95	5.7e-16	744.4434	2	0.24	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-03_FTMSms2hcd	67.934	230	243	43.0	5.3e-11	3.0e-13	5	49895.8	HUMAN	Tubulin alpha-1C chain
[10-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	6	22.3	8.95	5.7e-16	851.4585	2	2.3	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-03_FTMSms2hcd	57.574	65	79	47.7	6.1e-11	1.1e-13	3	49895.8	HUMAN	Tubulin alpha-1C chain
[10-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	6	22.3	8.95	5.7e-16	573.6328	3	1.1	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-03_FTMSms2hcd	34.418	216	229	31.6	1.6e-6	2.0e-9	7	49895.8	HUMAN	Tubulin alpha-1C chain
[10-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	6	22.3	8.95	5.7e-16	586.3239	3	-3.5	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-03_FTMSms2hcd	52.618	265	280	16.9	3.7e-6	8.5e-9	6	49895.8	HUMAN	Tubulin alpha-1C chain
[10-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	5	19.1	8.95	5.7e-16	800.0641	3	-0.36	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-03_FTMSms2hcd	49.300	85	105	47.6	5.7e-16	6.0e-19	6	50136.1	HUMAN	Tubulin alpha-1A chain
[10-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	5	19.1	8.95	5.7e-16	1004.4507	2	0.54	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-03_FTMSms2hcd	51.349	41	60	45.9	2.4e-13	2.7e-16	5	50136.1	HUMAN	Tubulin alpha-1A chain
[10-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	5	19.1	8.95	5.7e-16	851.4585	2	2.3	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-03_FTMSms2hcd	57.574	65	79	47.7	6.1e-11	1.1e-13	3	50136.1	HUMAN	Tubulin alpha-1A chain
[10-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	5	19.1	8.95	5.7e-16	573.6328	3	1.1	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-03_FTMSms2hcd	34.418	216	229	31.6	1.6e-6	2.0e-9	7	50136.1	HUMAN	Tubulin alpha-1A chain
[10-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	5	19.1	8.95	5.7e-16	586.3239	3	-3.5	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-03_FTMSms2hcd	52.618	265	280	16.9	3.7e-6	8.5e-9	6	50136.1	HUMAN	Tubulin alpha-1A chain
[10-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	4	15.8	8.95	5.7e-16	800.0641	3	-0.36	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-03_FTMSms2hcd	49.300	85	105	47.6	5.7e-16	6.0e-19	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[10-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	4	15.8	8.95	5.7e-16	1004.4507	2	0.54	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-03_FTMSms2hcd	51.349	41	60	45.9	2.4e-13	2.7e-16	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[10-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	4	15.8	8.95	5.7e-16	573.6328	3	1.1	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-03_FTMSms2hcd	34.418	216	229	31.6	1.6e-6	2.0e-9	7	49960.0	HUMAN	Tubulin alpha-3C/D chain
[10-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	4	15.8	8.95	5.7e-16	586.3239	3	-3.5	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-03_FTMSms2hcd	52.618	265	280	16.9	3.7e-6	8.5e-9	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[10-4]	0	P68366	TBA4A_HUMAN	TUBA4A	4	14.5	8.95	5.7e-16	800.0641	3	-0.36	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-03_FTMSms2hcd	49.300	85	105	47.6	5.7e-16	6.0e-19	6	49924.9	HUMAN	Tubulin alpha-4A chain
[10-4]	0	P68366	TBA4A_HUMAN	TUBA4A	4	14.5	8.95	5.7e-16	744.4434	2	0.24	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-03_FTMSms2hcd	67.934	230	243	43.0	5.3e-11	3.0e-13	5	49924.9	HUMAN	Tubulin alpha-4A chain
[10-4]	0	P68366	TBA4A_HUMAN	TUBA4A	4	14.5	8.95	5.7e-16	573.6328	3	1.1	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-03_FTMSms2hcd	34.418	216	229	31.6	1.6e-6	2.0e-9	7	49924.9	HUMAN	Tubulin alpha-4A chain
[10-4]	0	P68366	TBA4A_HUMAN	TUBA4A	4	14.5	8.95	5.7e-16	586.3239	3	-3.5	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-03_FTMSms2hcd	52.618	265	280	16.9	3.7e-6	8.5e-9	6	49924.9	HUMAN	Tubulin alpha-4A chain
[10-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	3	10.9	8.95	5.7e-16	800.0641	3	-0.36	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-03_FTMSms2hcd	49.300	85	105	47.6	5.7e-16	6.0e-19	6	50094.0	HUMAN	Tubulin alpha-8 chain
[10-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	3	10.9	8.95	5.7e-16	744.4434	2	0.24	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-03_FTMSms2hcd	67.934	230	243	43.0	5.3e-11	3.0e-13	5	50094.0	HUMAN	Tubulin alpha-8 chain
[10-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	3	10.9	8.95	5.7e-16	573.6328	3	1.1	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-03_FTMSms2hcd	34.418	216	229	31.6	1.6e-6	2.0e-9	7	50094.0	HUMAN	Tubulin alpha-8 chain
[10-6]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	3	11.1	7.53	2.4e-13	1004.4507	2	0.54	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-03_FTMSms2hcd	51.349	41	60	45.9	2.4e-13	2.7e-16	5	49859.0	HUMAN	Tubulin alpha-3E chain
[10-6]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	3	11.1	7.53	2.4e-13	573.6328	3	1.1	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-03_FTMSms2hcd	34.418	216	229	31.6	1.6e-6	2.0e-9	7	49859.0	HUMAN	Tubulin alpha-3E chain
[10-6]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	3	11.1	7.53	2.4e-13	586.3239	3	-3.5	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-03_FTMSms2hcd	52.618	265	280	16.9	3.7e-6	8.5e-9	6	49859.0	HUMAN	Tubulin alpha-3E chain
[10-7]	0	Q9H853	TBA4B_HUMAN	TUBA4B	1	5.8	6.27	5.3e-11	744.4434	2	0.24	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-03_FTMSms2hcd	67.934	169	182	43.0	5.3e-11	3.0e-13	5	27551.5	HUMAN	Putative tubulin-like protein alpha-4B
[11]		P11142	HSP7C_HUMAN	HSPA8	6	15.0	7.42	3.9e-13	846.3671	2	0.79	STAGDTHLGGEDFDNR	STAGDTHLGGEDFDNR		16	V20130429-03_FTMSms2hcd	23.218	221	236	51.8	3.9e-13	5.4e-16	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[11]		P11142	HSP7C_HUMAN	HSPA8	6	15.0	7.42	3.9e-13	991.5047	2	2.2	TVTNAVVTVPAYFNDSQR	TVTNAVVTVPAYFNDSQR		18	V20130429-03_FTMSms2hcd	46.347	138	155	44.6	4.4e-12	5.6e-15	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[11]		P11142	HSP7C_HUMAN	HSPA8	6	15.0	7.42	3.9e-13	744.3552	2	1.2	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-03_FTMSms2hcd	34.949	37	49	42.6	4.8e-12	6.0e-15	6	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[11]		P11142	HSP7C_HUMAN	HSPA8	6	15.0	7.42	3.9e-13	600.3414	2	1.1	DAGTIAGLNVLR	DAGTIAGLNVLR		12	V20130429-03_FTMSms2hcd	45.770	160	171	39.1	5.3e-9	1.1e-11	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[11]		P11142	HSP7C_HUMAN	HSPA8	6	15.0	7.42	3.9e-13	614.8181	2	0.72	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-03_FTMSms2hcd	21.016	26	36	42.6	2.0e-8	2.9e-11	7	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[11]		P11142	HSP7C_HUMAN	HSPA8	6	15.0	7.42	3.9e-13	999.8300	3	6.0	TLSSSTQASIEIDSLYEGIDFYTSITR	TLSSSTQASIEIDSLYEGIDFYTSITR		27	V20130429-03_FTMSms2hcd	74.241	273	299	14.3	1.5e-5	1.6e-8	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[11-1]	0	P54652	HSP72_HUMAN	HSPA2	3	6.3	7.42	3.9e-13	846.3671	2	0.79	STAGDTHLGGEDFDNR	STAGDTHLGGEDFDNR		16	V20130429-03_FTMSms2hcd	23.218	224	239	51.8	3.9e-13	5.4e-16	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[11-1]	0	P54652	HSP72_HUMAN	HSPA2	3	6.3	7.42	3.9e-13	744.3552	2	1.2	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-03_FTMSms2hcd	34.949	38	50	42.6	4.8e-12	6.0e-15	6	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[11-1]	0	P54652	HSP72_HUMAN	HSPA2	3	6.3	7.42	3.9e-13	614.8181	2	0.72	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-03_FTMSms2hcd	21.016	27	37	42.6	2.0e-8	2.9e-11	7	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[11-2]	1	P11021	GRP78_HUMAN	HSPA5	2	3.8	6.92	3.3e-12	776.9030	2	3.9	TFAPEEISAMVLTK	TFAPEEISAM(Oxidation)VLTK	Oxidation@148	14	V20130429-03_FTMSms2hcd	48.396	139	152	45.4	3.3e-12	4.7e-15	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[11-2]	1	P11021	GRP78_HUMAN	HSPA5	2	3.8	6.92	3.3e-12	614.8181	2	0.72	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-03_FTMSms2hcd	21.016	50	60	42.6	2.0e-8	2.9e-11	7	72333.5	HUMAN	78 kDa glucose-regulated protein
[11-3]	0	P08107	HSP71_HUMAN	HSPA1A	2	3.7	6.83	4.8e-12	744.3552	2	1.2	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-03_FTMSms2hcd	34.949	37	49	42.6	4.8e-12	6.0e-15	6	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[11-3]	0	P08107	HSP71_HUMAN	HSPA1A	2	3.7	6.83	4.8e-12	614.8181	2	0.72	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-03_FTMSms2hcd	21.016	26	36	42.6	2.0e-8	2.9e-11	7	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[11-4]	0	P17066	HSP76_HUMAN	HSPA6	2	3.7	6.83	4.8e-12	744.3552	2	1.2	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-03_FTMSms2hcd	34.949	39	51	42.6	4.8e-12	6.0e-15	6	71028.7	HUMAN	Heat shock 70 kDa protein 6
[11-4]	0	P17066	HSP76_HUMAN	HSPA6	2	3.7	6.83	4.8e-12	614.8181	2	0.72	VEILANDQGNR	VEILANDQGNR		11	V20130429-03_FTMSms2hcd	21.016	28	38	42.6	2.0e-8	2.9e-11	7	71028.7	HUMAN	Heat shock 70 kDa protein 6
[11-5]	0	P34931	HS71L_HUMAN	HSPA1L	2	3.7	6.83	4.8e-12	744.3552	2	1.2	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-03_FTMSms2hcd	34.949	39	51	42.6	4.8e-12	6.0e-15	6	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[11-5]	0	P34931	HS71L_HUMAN	HSPA1L	2	3.7	6.83	4.8e-12	614.8181	2	0.72	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-03_FTMSms2hcd	21.016	28	38	42.6	2.0e-8	2.9e-11	7	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[11-6]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	6.83	4.8e-12	744.3552	2	1.2	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-03_FTMSms2hcd	34.949	39	51	42.6	4.8e-12	6.0e-15	6	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[11-6]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	6.83	4.8e-12	614.8181	2	0.72	VEILANDQGNR	VEILANDQGNR		11	V20130429-03_FTMSms2hcd	21.016	28	38	42.6	2.0e-8	2.9e-11	7	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[12]		P12814	ACTN1_HUMAN	ACTN1	7	8.1	7.06	1.8e-12	675.3250	3	1.1	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@239	18	V20130429-03_FTMSms2hcd	53.970	237	254	36.5	1.8e-12	1.8e-15	2	103058.4	HUMAN	Alpha-actinin-1
[12]		P12814	ACTN1_HUMAN	ACTN1	7	8.1	7.06	1.8e-12	693.8908	2	0.25	VGWEQLLTTIAR	VGWEQLLTTIAR		12	V20130429-03_FTMSms2hcd	65.908	715	726	41.3	2.1e-10	4.2e-13	2	103058.4	HUMAN	Alpha-actinin-1
[12]		P12814	ACTN1_HUMAN	ACTN1	7	8.1	7.06	1.8e-12	623.3423	3	-2.2	LLETIDQLYLEYAKR	LLETIDQLYLEYAKR		15	V20130429-03_FTMSms2hcd	58.457	503	517	28.6	1.0e-9	2.5e-12	1	103058.4	HUMAN	Alpha-actinin-1
[12]		P12814	ACTN1_HUMAN	ACTN1	7	8.1	7.06	1.8e-12	669.9934	3	1.2	AIMTYVSSFYHAFSGAQK	AIMTYVSSFYHAFSGAQK		18	V20130429-03_FTMSms2hcd	61.387	237	254	19.6	1.8e-7	1.9e-10	2	103058.4	HUMAN	Alpha-actinin-1
[12]		P12814	ACTN1_HUMAN	ACTN1	7	8.1	7.06	1.8e-12	715.3842	2	-2.4	TINEVENQILTR	TINEVENQILTR		12	V20130429-03_FTMSms2hcd	39.042	727	738	37.0	2.9e-7	5.0e-10	2	103058.4	HUMAN	Alpha-actinin-1
[12]		P12814	ACTN1_HUMAN	ACTN1	7	8.1	7.06	1.8e-12	685.0897	4	12	AIMTYVSSFYHAFSGAQKAETAANR	AIM(Oxidation)TYVSSFYHAFSGAQKAETAANR	Oxidation@239	25	V20130429-03_FTMSms2hcd	51.668	237	261	16.9	2.5e-6	2.7e-9	2	103058.4	HUMAN	Alpha-actinin-1
[12]		P12814	ACTN1_HUMAN	ACTN1	7	8.1	7.06	1.8e-12	472.7300	2	4.1	ALDFIASK	ALDFIAS(Phospho)K	Phospho@102	8	V20130429-03_FTMSms2hcd	31.798	96	103	12.8	0.011	2.0e-5	3	103058.4	HUMAN	Alpha-actinin-1
[12-1]	0	O43707	ACTN4_HUMAN	ACTN4	6	6.3	7.06	1.8e-12	675.3250	3	1.1	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@258	18	V20130429-03_FTMSms2hcd	53.970	256	273	36.5	1.8e-12	1.8e-15	2	104854.9	HUMAN	Alpha-actinin-4
[12-1]	0	O43707	ACTN4_HUMAN	ACTN4	6	6.3	7.06	1.8e-12	693.8908	2	0.25	VGWEQLLTTIAR	VGWEQLLTTIAR		12	V20130429-03_FTMSms2hcd	65.908	734	745	41.3	2.1e-10	4.2e-13	2	104854.9	HUMAN	Alpha-actinin-4
[12-1]	0	O43707	ACTN4_HUMAN	ACTN4	6	6.3	7.06	1.8e-12	669.9934	3	1.2	AIMTYVSSFYHAFSGAQK	AIMTYVSSFYHAFSGAQK		18	V20130429-03_FTMSms2hcd	61.387	256	273	19.6	1.8e-7	1.9e-10	2	104854.9	HUMAN	Alpha-actinin-4
[12-1]	0	O43707	ACTN4_HUMAN	ACTN4	6	6.3	7.06	1.8e-12	715.3842	2	-2.4	TINEVENQILTR	TINEVENQILTR		12	V20130429-03_FTMSms2hcd	39.042	746	757	37.0	2.9e-7	5.0e-10	2	104854.9	HUMAN	Alpha-actinin-4
[12-1]	0	O43707	ACTN4_HUMAN	ACTN4	6	6.3	7.06	1.8e-12	685.0897	4	12	AIMTYVSSFYHAFSGAQKAETAANR	AIM(Oxidation)TYVSSFYHAFSGAQKAETAANR	Oxidation@258	25	V20130429-03_FTMSms2hcd	51.668	256	280	16.9	2.5e-6	2.7e-9	2	104854.9	HUMAN	Alpha-actinin-4
[12-1]	0	O43707	ACTN4_HUMAN	ACTN4	6	6.3	7.06	1.8e-12	472.7300	2	4.1	ALDFIASK	ALDFIAS(Phospho)K	Phospho@121	8	V20130429-03_FTMSms2hcd	31.798	115	122	12.8	0.011	2.0e-5	3	104854.9	HUMAN	Alpha-actinin-4
[13]		P10809	CH60_HUMAN	HSPD1	6	20.1	7.91	4.9e-14	715.7149	3	0.35	ALMLQGVDLLADAVAVTMGPK	ALM(Oxidation)LQGVDLLADAVAVTM(Oxidation)GPK	Oxidation@40;Oxidation@55	21	V20130429-03_FTMSms2hcd	70.482	38	58	47.2	4.9e-14	8.6e-17	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[13]		P10809	CH60_HUMAN	HSPD1	6	20.1	7.91	4.9e-14	646.9872	3	-0.35	TLNDELEIIEGMKFDR	TLNDELEIIEGM(Oxidation)KFDR	Oxidation@217	16	V20130429-03_FTMSms2hcd	50.604	206	221	32.5	1.2e-11	1.3e-14	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[13]		P10809	CH60_HUMAN	HSPD1	6	20.1	7.91	4.9e-14	401.5783	3	2.2	TLKIPAMTIAK	TLKIPAM(Oxidation)TIAK	Oxidation@477	11	V20130429-03_FTMSms2hcd	29.147	471	481	20.2	6.1e-9	3.1e-11	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[13]		P10809	CH60_HUMAN	HSPD1	6	20.1	7.91	4.9e-14	524.9729	3	0.77	GVMLAVDAVIAELKK	GVM(Oxidation)LAVDAVIAELKK	Oxidation@145	15	V20130429-03_FTMSms2hcd	59.659	143	157	34.2	9.5e-8	4.3e-10	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[13]		P10809	CH60_HUMAN	HSPD1	6	20.1	7.91	4.9e-14	853.8883	5	6.0	ISSIQSIVPALEIANAHRKPLVIIAEDVDGEALSTLVLNR	ISSIQSIVPALEIANAHRKPLVIIAEDVDGEALSTLVLNR		40	V20130429-03_FTMSms2hcd	75.464	251	290	23.2	1.2e-7	3.5e-9	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[13]		P10809	CH60_HUMAN	HSPD1	6	20.1	7.91	4.9e-14	672.8632	2	2.5	TVIIEQSWGSPK	TVIIEQSWGSPK		12	V20130429-03_FTMSms2hcd	36.990	61	72	31.7	9.2e-7	1.5e-9	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[14]		P07355	ANXA2_HUMAN	ANXA2	5	21.2	7.12	1.4e-12	550.9977	3	-0.20	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-03_FTMSms2hcd	70.068	89	104	44.2	1.4e-12	2.0e-14	2	38604.4	HUMAN	Annexin A2
[14]		P07355	ANXA2_HUMAN	ANXA2	5	21.2	7.12	1.4e-12	771.9282	2	0.34	GVDEVTIVNILTNR	GVDEVTIVNILTNR		14	V20130429-03_FTMSms2hcd	59.779	50	63	49.1	1.0e-10	2.4e-13	1	38604.4	HUMAN	Annexin A2
[14]		P07355	ANXA2_HUMAN	ANXA2	5	21.2	7.12	1.4e-12	485.7462	4	1.2	TDLEKDIISDTSGDFRK	TDLEKDIISDTSGDFRK		17	V20130429-03_FTMSms2hcd	40.963	153	169	32.8	2.4e-10	2.9e-13	2	38604.4	HUMAN	Annexin A2
[14]		P07355	ANXA2_HUMAN	ANXA2	5	21.2	7.12	1.4e-12	536.2791	2	0.58	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-03_FTMSms2hcd	34.383	1	10	37.8	4.5e-10	8.2e-13	2	38604.4	HUMAN	Annexin A2
[14]		P07355	ANXA2_HUMAN	ANXA2	5	21.2	7.12	1.4e-12	828.4014	2	0.61	TPAQYDASELKASMK	TPAQYDASELKASM(Oxidation)K	Oxidation@118	15	V20130429-03_FTMSms2hcd	21.646	105	119	24.6	1.4e-6	1.5e-9	2	38604.4	HUMAN	Annexin A2
[14-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	4	17.1	7.12	1.4e-12	550.9977	3	-0.20	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-03_FTMSms2hcd	70.068	89	104	44.2	1.4e-12	2.0e-14	2	38659.3	HUMAN	Putative annexin A2-like protein
[14-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	4	17.1	7.12	1.4e-12	485.7462	4	1.2	TDLEKDIISDTSGDFRK	TDLEKDIISDTSGDFRK		17	V20130429-03_FTMSms2hcd	40.963	153	169	32.8	2.4e-10	2.9e-13	2	38659.3	HUMAN	Putative annexin A2-like protein
[14-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	4	17.1	7.12	1.4e-12	536.2791	2	0.58	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-03_FTMSms2hcd	34.383	1	10	37.8	4.5e-10	8.2e-13	2	38659.3	HUMAN	Putative annexin A2-like protein
[14-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	4	17.1	7.12	1.4e-12	828.4014	2	0.61	TPAQYDASELKASMK	TPAQYDASELKASM(Oxidation)K	Oxidation@118	15	V20130429-03_FTMSms2hcd	21.646	105	119	24.6	1.4e-6	1.5e-9	2	38659.3	HUMAN	Putative annexin A2-like protein
[15]		P62937	PPIA_HUMAN	PPIA	4	40.6	7.89	5.4e-14	917.4418	3	3.0	HTGPGILSMANAGPNTNGSQFFICTAK	HTGPGILSM(Oxidation)ANAGPNTNGSQFFICTAK	Oxidation@100	27	V20130429-03_FTMSms2hcd	48.341	92	118	52.6	5.4e-14	5.1e-17	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[15]		P62937	PPIA_HUMAN	PPIA	4	40.6	7.89	5.4e-14	758.4025	2	1.5	TEWLDGKHVVFGK	TEWLDGKHVVFGK		13	V20130429-03_FTMSms2hcd	37.003	119	131	37.7	9.2e-11	1.5e-13	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[15]		P62937	PPIA_HUMAN	PPIA	4	40.6	7.89	5.4e-14	916.4619	2	2.9	SIYGEKFEDENFILK	SIYGEKFEDENFILK		15	V20130429-03_FTMSms2hcd	46.901	77	91	29.1	1.0e-10	1.2e-13	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[15]		P62937	PPIA_HUMAN	PPIA	4	40.6	7.89	5.4e-14	690.3884	2	9.1	VSFELFADKVPK	VSFELFADKVPK		12	V20130429-03_FTMSms2hcd	47.752	20	31	30.4	1.9e-6	5.5e-9	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[16]		P07737	PROF1_HUMAN	PFN1	5	35.7	8.26	1.1e-14	958.0380	2	2.1	TFVNITPAEVGVLVGKDR	TFVNITPAEVGVLVGKDR		18	V20130429-03_FTMSms2hcd	54.878	39	56	52.4	1.1e-14	4.6e-17	1	15054.4	HUMAN	Profilin-1
[16]		P07737	PROF1_HUMAN	PFN1	5	35.7	8.26	1.1e-14	822.4726	2	0.75	TFVNITPAEVGVLVGK	TFVNITPAEVGVLVGK		16	V20130429-03_FTMSms2hcd	58.927	39	54	34.2	9.5e-11	3.7e-13	1	15054.4	HUMAN	Profilin-1
[16]		P07737	PROF1_HUMAN	PFN1	5	35.7	8.26	1.1e-14	445.7731	2	1.1	TLVLLMGK	TLVLLM(Oxidation)GK	Oxidation@114	8	V20130429-03_FTMSms2hcd	35.217	109	116	22.9	2.4e-9	1.5e-11	1	15054.4	HUMAN	Profilin-1
[16]		P07737	PROF1_HUMAN	PFN1	5	35.7	8.26	1.1e-14	735.8834	2	0.55	SSFYVNGLTLGGQK	SSFYVNGLTLGGQK		14	V20130429-03_FTMSms2hcd	44.641	57	70	14.9	1.4e-4	2.1e-7	1	15054.4	HUMAN	Profilin-1
[16]		P07737	PROF1_HUMAN	PFN1	5	35.7	8.26	1.1e-14	673.2833	2	3.9	CYEMASHLRR	CY(Phospho)EMASHLRR	Phospho@129=34	10	V20130429-03_FTMSms2hcd	15.839	128	137	10.7	0.074	1.5e-4	1	15054.4	HUMAN	Profilin-1
[17]		P05783	K1C18_HUMAN	KRT18	3	12.8	8.81	1.0e-15	1143.5652	3	3.1	YWSQQIEESTTVVTTQSAEVGAAETTLTELR	YWSQQIEESTTVVTTQSAEVGAAETTLTELR		31	V20130429-03_FTMSms2hcd	63.704	270	300	57.6	1.0e-15	1.2e-18	1	48058.2	HUMAN	Keratin, type I cytoskeletal 18
[17]		P05783	K1C18_HUMAN	KRT18	3	12.8	8.81	1.0e-15	896.9487	4	0.42	YWSQQIEESTTVVTTQSAEVGAAETTLTELRR	YWSQQIEESTTVVTTQSAEVGAAETTLTELRR		32	V20130429-03_FTMSms2hcd	60.830	270	301	46.2	7.9e-14	1.1e-16	1	48058.2	HUMAN	Keratin, type I cytoskeletal 18
[17]		P05783	K1C18_HUMAN	KRT18	3	12.8	8.81	1.0e-15	896.1315	3	-2.6	YALQMEQLNGILLHLESELAQTR	YALQM(Oxidation)EQLNGILLHLESELAQTR	Oxidation@335	23	V20130429-03_FTMSms2hcd	73.045	331	353	36.0	2.7e-12	4.2e-15	1	48058.2	HUMAN	Keratin, type I cytoskeletal 18
[18]		P19338	NUCL_HUMAN	NCL	4	8.9	7.40	4.2e-13	1251.1385	2	1.6	TLVLSNLSYSATEETLQEVFEK	TLVLSNLSYSATEETLQEVFEK		22	V20130429-03_FTMSms2hcd	71.167	487	508	45.9	4.2e-13	5.7e-16	1	76615.0	HUMAN	Nucleolin
[18]		P19338	NUCL_HUMAN	NCL	4	8.9	7.40	4.2e-13	640.3461	3	0.25	TGISDVFAKNDLAVVDVR	TGISDVFAKNDLAVVDVR		18	V20130429-03_FTMSms2hcd	52.661	325	342	31.0	3.4e-10	6.5e-13	1	76615.0	HUMAN	Nucleolin
[18]		P19338	NUCL_HUMAN	NCL	4	8.9	7.40	4.2e-13	653.3124	4	-0.59	GYAFIEFASFEDAKEALNSCNKR	GYAFIEFASFEDAKEALNSCNKR		23	V20130429-03_FTMSms2hcd	59.582	524	546	24.0	2.7e-9	2.5e-12	1	76615.0	HUMAN	Nucleolin
[18]		P19338	NUCL_HUMAN	NCL	4	8.9	7.40	4.2e-13	469.2534	2	0.64	TGISDVFAK	TGISDVFAK		9	V20130429-03_FTMSms2hcd	35.732	325	333	26.1	1.8e-5	3.5e-8	1	76615.0	HUMAN	Nucleolin
[19]		Q16777	H2A2C_HUMAN	HIST2H2AC	5	58.1	6.46	2.3e-11	983.8501	3	-1.1	VGAGAPVYMAAVLEYLTAEILELAGNAAR	VGAGAPVYM(Oxidation)AAVLEYLTAEILELAGNAAR	Oxidation@52	29	V20130429-03_FTMSms2hcd	78.199	44	72	50.6	2.3e-11	4.6e-14	2	13988.5	HUMAN	Histone H2A type 2-C
[19]		Q16777	H2A2C_HUMAN	HIST2H2AC	5	58.1	6.46	2.3e-11	644.3942	3	-0.39	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-03_FTMSms2hcd	65.654	101	119	30.8	1.3e-9	3.4e-11	10	13988.5	HUMAN	Histone H2A type 2-C
[19]		Q16777	H2A2C_HUMAN	HIST2H2AC	5	58.1	6.46	2.3e-11	526.8025	4	0.41	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-03_FTMSms2hcd	46.160	83	100	27.9	2.6e-6	1.4e-8	7	13988.5	HUMAN	Histone H2A type 2-C
[19]		Q16777	H2A2C_HUMAN	HIST2H2AC	5	58.1	6.46	2.3e-11	425.7682	2	4.0	HLQLAIR	HLQLAIR		7	V20130429-03_FTMSms2hcd	26.183	83	89	28.8	2.0e-4	2.0e-6	14	13988.5	HUMAN	Histone H2A type 2-C
[19]		Q16777	H2A2C_HUMAN	HIST2H2AC	5	58.1	6.46	2.3e-11	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-03_FTMSms2hcd	36.713	22	30	28.4	6.3e-4	1.1e-6	15	13988.5	HUMAN	Histone H2A type 2-C
[19-1]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	5	57.7	6.46	2.3e-11	983.8501	3	-1.1	VGAGAPVYMAAVLEYLTAEILELAGNAAR	VGAGAPVYM(Oxidation)AAVLEYLTAEILELAGNAAR	Oxidation@52	29	V20130429-03_FTMSms2hcd	78.199	44	72	50.6	2.3e-11	4.6e-14	2	14095.6	HUMAN	Histone H2A type 2-A
[19-1]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	5	57.7	6.46	2.3e-11	644.3942	3	-0.39	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-03_FTMSms2hcd	65.654	101	119	30.8	1.3e-9	3.4e-11	10	14095.6	HUMAN	Histone H2A type 2-A
[19-1]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	5	57.7	6.46	2.3e-11	526.8025	4	0.41	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-03_FTMSms2hcd	46.160	83	100	27.9	2.6e-6	1.4e-8	7	14095.6	HUMAN	Histone H2A type 2-A
[19-1]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	5	57.7	6.46	2.3e-11	425.7682	2	4.0	HLQLAIR	HLQLAIR		7	V20130429-03_FTMSms2hcd	26.183	83	89	28.8	2.0e-4	2.0e-6	14	14095.6	HUMAN	Histone H2A type 2-A
[19-1]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	5	57.7	6.46	2.3e-11	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-03_FTMSms2hcd	36.713	22	30	28.4	6.3e-4	1.1e-6	15	14095.6	HUMAN	Histone H2A type 2-A
[19-2]	1	P0C0S5	H2AZ_HUMAN	H2AFZ	3	35.2	7.76	9.3e-14	965.8525	3	2.8	VGATAAVYSAAILEYLTAEVLELAGNASK	VGATAAVYSAAILEYLTAEVLELAGNASK		29	V20130429-03_FTMSms2hcd	78.449	47	75	48.0	9.3e-14	2.7e-16	2	13552.8	HUMAN	Histone H2A.Z
[19-2]	1	P0C0S5	H2AZ_HUMAN	H2AFZ	3	35.2	7.76	9.3e-14	425.7682	2	4.0	HLQLAIR	HLQLAIR		7	V20130429-03_FTMSms2hcd	26.183	86	92	28.8	2.0e-4	2.0e-6	14	13552.8	HUMAN	Histone H2A.Z
[19-2]	1	P0C0S5	H2AZ_HUMAN	H2AFZ	3	35.2	7.76	9.3e-14	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-03_FTMSms2hcd	36.713	24	32	28.4	6.3e-4	1.1e-6	15	13552.8	HUMAN	Histone H2A.Z
[19-3]	1	Q71UI9	H2AV_HUMAN	H2AFV	3	35.2	7.76	9.3e-14	965.8525	3	2.8	VGATAAVYSAAILEYLTAEVLELAGNASK	VGATAAVYSAAILEYLTAEVLELAGNASK		29	V20130429-03_FTMSms2hcd	78.449	47	75	48.0	9.3e-14	2.7e-16	2	13508.8	HUMAN	Histone H2A.V
[19-3]	1	Q71UI9	H2AV_HUMAN	H2AFV	3	35.2	7.76	9.3e-14	425.7682	2	4.0	HLQLAIR	HLQLAIR		7	V20130429-03_FTMSms2hcd	26.183	86	92	28.8	2.0e-4	2.0e-6	14	13508.8	HUMAN	Histone H2A.V
[19-3]	1	Q71UI9	H2AV_HUMAN	H2AFV	3	35.2	7.76	9.3e-14	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-03_FTMSms2hcd	36.713	24	32	28.4	6.3e-4	1.1e-6	15	13508.8	HUMAN	Histone H2A.V
[19-4]	0	P0C0S8	H2A1_HUMAN	HIST1H2AG	4	35.4	4.60	1.3e-9	644.3942	3	-0.39	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-03_FTMSms2hcd	65.654	101	119	30.8	1.3e-9	3.4e-11	10	14091.6	HUMAN	Histone H2A type 1
[19-4]	0	P0C0S8	H2A1_HUMAN	HIST1H2AG	4	35.4	4.60	1.3e-9	526.8025	4	0.41	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-03_FTMSms2hcd	46.160	83	100	27.9	2.6e-6	1.4e-8	7	14091.6	HUMAN	Histone H2A type 1
[19-4]	0	P0C0S8	H2A1_HUMAN	HIST1H2AG	4	35.4	4.60	1.3e-9	425.7682	2	4.0	HLQLAIR	HLQLAIR		7	V20130429-03_FTMSms2hcd	26.183	83	89	28.8	2.0e-4	2.0e-6	14	14091.6	HUMAN	Histone H2A type 1
[19-4]	0	P0C0S8	H2A1_HUMAN	HIST1H2AG	4	35.4	4.60	1.3e-9	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-03_FTMSms2hcd	36.713	22	30	28.4	6.3e-4	1.1e-6	15	14091.6	HUMAN	Histone H2A type 1
[19-5]	0	P20671	H2A1D_HUMAN	HIST1H2AD	4	35.4	4.60	1.3e-9	644.3942	3	-0.39	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-03_FTMSms2hcd	65.654	101	119	30.8	1.3e-9	3.4e-11	10	14107.6	HUMAN	Histone H2A type 1-D
[19-5]	0	P20671	H2A1D_HUMAN	HIST1H2AD	4	35.4	4.60	1.3e-9	526.8025	4	0.41	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-03_FTMSms2hcd	46.160	83	100	27.9	2.6e-6	1.4e-8	7	14107.6	HUMAN	Histone H2A type 1-D
[19-5]	0	P20671	H2A1D_HUMAN	HIST1H2AD	4	35.4	4.60	1.3e-9	425.7682	2	4.0	HLQLAIR	HLQLAIR		7	V20130429-03_FTMSms2hcd	26.183	83	89	28.8	2.0e-4	2.0e-6	14	14107.6	HUMAN	Histone H2A type 1-D
[19-5]	0	P20671	H2A1D_HUMAN	HIST1H2AD	4	35.4	4.60	1.3e-9	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-03_FTMSms2hcd	36.713	22	30	28.4	6.3e-4	1.1e-6	15	14107.6	HUMAN	Histone H2A type 1-D
[19-6]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	4	35.9	4.60	1.3e-9	644.3942	3	-0.39	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-03_FTMSms2hcd	65.654	101	119	30.8	1.3e-9	3.4e-11	10	13906.4	HUMAN	Histone H2A type 1-H
[19-6]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	4	35.9	4.60	1.3e-9	526.8025	4	0.41	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-03_FTMSms2hcd	46.160	83	100	27.9	2.6e-6	1.4e-8	7	13906.4	HUMAN	Histone H2A type 1-H
[19-6]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	4	35.9	4.60	1.3e-9	425.7682	2	4.0	HLQLAIR	HLQLAIR		7	V20130429-03_FTMSms2hcd	26.183	83	89	28.8	2.0e-4	2.0e-6	14	13906.4	HUMAN	Histone H2A type 1-H
[19-6]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	4	35.9	4.60	1.3e-9	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-03_FTMSms2hcd	36.713	22	30	28.4	6.3e-4	1.1e-6	15	13906.4	HUMAN	Histone H2A type 1-H
[19-7]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	4	35.9	4.60	1.3e-9	644.3942	3	-0.39	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-03_FTMSms2hcd	65.654	101	119	30.8	1.3e-9	3.4e-11	10	13936.4	HUMAN	Histone H2A type 1-J
[19-7]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	4	35.9	4.60	1.3e-9	526.8025	4	0.41	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-03_FTMSms2hcd	46.160	83	100	27.9	2.6e-6	1.4e-8	7	13936.4	HUMAN	Histone H2A type 1-J
[19-7]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	4	35.9	4.60	1.3e-9	425.7682	2	4.0	HLQLAIR	HLQLAIR		7	V20130429-03_FTMSms2hcd	26.183	83	89	28.8	2.0e-4	2.0e-6	14	13936.4	HUMAN	Histone H2A type 1-J
[19-7]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	4	35.9	4.60	1.3e-9	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-03_FTMSms2hcd	36.713	22	30	28.4	6.3e-4	1.1e-6	15	13936.4	HUMAN	Histone H2A type 1-J
[19-8]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	4	35.7	4.60	1.3e-9	644.3942	3	-0.39	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-03_FTMSms2hcd	65.654	101	119	30.8	1.3e-9	3.4e-11	10	14019.5	HUMAN	Histone H2A.J
[19-8]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	4	35.7	4.60	1.3e-9	526.8025	4	0.41	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-03_FTMSms2hcd	46.160	83	100	27.9	2.6e-6	1.4e-8	7	14019.5	HUMAN	Histone H2A.J
[19-8]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	4	35.7	4.60	1.3e-9	425.7682	2	4.0	HLQLAIR	HLQLAIR		7	V20130429-03_FTMSms2hcd	26.183	83	89	28.8	2.0e-4	2.0e-6	14	14019.5	HUMAN	Histone H2A.J
[19-8]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	4	35.7	4.60	1.3e-9	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-03_FTMSms2hcd	36.713	22	30	28.4	6.3e-4	1.1e-6	15	14019.5	HUMAN	Histone H2A.J
[19-9]	0	P04908	H2A1B_HUMAN	HIST1H2AB	3	26.9	4.60	1.3e-9	644.3942	3	-0.39	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-03_FTMSms2hcd	65.654	101	119	30.8	1.3e-9	3.4e-11	10	14135.6	HUMAN	Histone H2A type 1-B/E
[19-9]	0	P04908	H2A1B_HUMAN	HIST1H2AB	3	26.9	4.60	1.3e-9	425.7682	2	4.0	HLQLAIR	HLQLAIR		7	V20130429-03_FTMSms2hcd	26.183	83	89	28.8	2.0e-4	2.0e-6	14	14135.6	HUMAN	Histone H2A type 1-B/E
[19-9]	0	P04908	H2A1B_HUMAN	HIST1H2AB	3	26.9	4.60	1.3e-9	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-03_FTMSms2hcd	36.713	22	30	28.4	6.3e-4	1.1e-6	15	14135.6	HUMAN	Histone H2A type 1-B/E
[19-10]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	3	26.9	4.60	1.3e-9	644.3942	3	-0.39	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-03_FTMSms2hcd	65.654	101	119	30.8	1.3e-9	3.4e-11	10	14121.6	HUMAN	Histone H2A type 3
[19-10]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	3	26.9	4.60	1.3e-9	425.7682	2	4.0	HLQLAIR	HLQLAIR		7	V20130429-03_FTMSms2hcd	26.183	83	89	28.8	2.0e-4	2.0e-6	14	14121.6	HUMAN	Histone H2A type 3
[19-10]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	3	26.9	4.60	1.3e-9	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-03_FTMSms2hcd	36.713	22	30	28.4	6.3e-4	1.1e-6	15	14121.6	HUMAN	Histone H2A type 3
[19-11]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	3	26.9	4.60	1.3e-9	644.3942	3	-0.39	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-03_FTMSms2hcd	65.654	101	119	30.8	1.3e-9	3.4e-11	10	14105.6	HUMAN	Histone H2A type 1-C
[19-11]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	3	26.9	4.60	1.3e-9	425.7682	2	4.0	HLQLAIR	HLQLAIR		7	V20130429-03_FTMSms2hcd	26.183	83	89	28.8	2.0e-4	2.0e-6	14	14105.6	HUMAN	Histone H2A type 1-C
[19-11]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	3	26.9	4.60	1.3e-9	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-03_FTMSms2hcd	36.713	22	30	28.4	6.3e-4	1.1e-6	15	14105.6	HUMAN	Histone H2A type 1-C
[19-12]	0	P16104	H2AX_HUMAN	H2AFX	2	11.2	1.60	2.0e-4	425.7682	2	4.0	HLQLAIR	HLQLAIR		7	V20130429-03_FTMSms2hcd	26.183	83	89	28.8	2.0e-4	2.0e-6	14	15144.7	HUMAN	Histone H2A.x
[19-12]	0	P16104	H2AX_HUMAN	H2AFX	2	11.2	1.60	2.0e-4	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-03_FTMSms2hcd	36.713	22	30	28.4	6.3e-4	1.1e-6	15	15144.7	HUMAN	Histone H2A.x
[19-13]	0	Q96QV6	H2A1A_HUMAN	HIST1H2AA	2	12.2	1.60	2.0e-4	425.7682	2	4.0	HLQLAIR	HLQLAIR		7	V20130429-03_FTMSms2hcd	26.183	83	89	28.8	2.0e-4	2.0e-6	14	14233.6	HUMAN	Histone H2A type 1-A
[19-13]	0	Q96QV6	H2A1A_HUMAN	HIST1H2AA	2	12.2	1.60	2.0e-4	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-03_FTMSms2hcd	36.713	22	30	28.4	6.3e-4	1.1e-6	15	14233.6	HUMAN	Histone H2A type 1-A
[19-14]	0	Q8IUE6	H2A2B_HUMAN	HIST2H2AB	1	6.9	1.29	6.3e-4	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-03_FTMSms2hcd	36.713	22	30	28.4	6.3e-4	1.1e-6	15	13995.4	HUMAN	Histone H2A type 2-B
[20]		P09651	ROA1_HUMAN	HNRNPA1	3	14.5	9.34	1.1e-16	847.8541	2	0.49	NQGGYGGSSSSSSYGSGR	NQGGYGGSSSSSSYGSGR		18	V20130429-03_FTMSms2hcd	12.717	353	370	48.3	1.1e-16	1.6e-19	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[20]		P09651	ROA1_HUMAN	HNRNPA1	3	14.5	9.34	1.1e-16	892.9598	2	3.3	LFIGGLSFETTDESLR	LFIGGLSFETTDESLR		16	V20130429-03_FTMSms2hcd	58.470	16	31	31.9	7.7e-9	1.1e-11	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[20]		P09651	ROA1_HUMAN	HNRNPA1	3	14.5	9.34	1.1e-16	761.0539	3	-1.2	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-03_FTMSms2hcd	52.941	147	166	27.4	8.4e-8	1.1e-10	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[20-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	2	11.2	4.29	7.7e-9	892.9598	2	3.3	LFIGGLSFETTDESLR	LFIGGLSFETTDESLR		16	V20130429-03_FTMSms2hcd	58.470	16	31	31.9	7.7e-9	1.1e-11	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[20-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	2	11.2	4.29	7.7e-9	761.0539	3	-1.2	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-03_FTMSms2hcd	52.941	147	166	27.4	8.4e-8	1.1e-10	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[21]		P02765	FETUA_HUMAN	AHSG	4	3.5	6.04	8.1e-12	640.7576	2	1.6	CDSSPDSAEDVR	CDSSPDSAEDVR		12	V20130429-03_FTMSms2hcd	13.904	132	143	33.3	8.1e-12	2.0e-14	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[21]		P02765	FETUA_HUMAN	AHSG	4	3.5	6.04	8.1e-12	744.7900	2	3.7	CDSSPDSAEDVRK	CDSSPDS(Phospho)AEDVRK	Phospho@138=7	13	V20130429-03_FTMSms2hcd	11.728	132	144	33.3	4.1e-10	1.1e-12	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[21]		P02765	FETUA_HUMAN	AHSG	4	3.5	6.04	8.1e-12	704.8044	2	0.44	CDSSPDSAEDVRK	CDSSPDSAEDVRK		13	V20130429-03_FTMSms2hcd	10.884	132	144	25.3	1.1e-8	1.9e-11	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[21]		P02765	FETUA_HUMAN	AHSG	4	3.5	6.04	8.1e-12	784.7700	2	-0.53	CDSSPDSAEDVRK	CDS(Phospho)SPDS(Phospho)AEDVRK	Phospho@138=14;Phospho@134|135	13	V20130429-03_FTMSms2hcd	13.092	132	144	15.6	5.9e-5	2.8e-7	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[22]		P31947	1433S_HUMAN	SFN	3	25.4	8.92	6.7e-16	844.9008	4	-3.2	TTFDEAMADLHTLSEDSYKDSTLIMQLLR	TTFDEAM(Oxidation)ADLHTLSEDSYKDSTLIM(Oxidation)QLLR	Oxidation@202;Oxidation@220	29	V20130429-03_FTMSms2hcd	73.286	196	224	39.1	6.7e-16	6.4e-19	1	27774.3	HUMAN	14-3-3 protein sigma
[22]		P31947	1433S_HUMAN	SFN	3	25.4	8.92	6.7e-16	945.1647	3	0.87	LGLALNFSVFHYEIANSPEEAISLAK	LGLALNFSVFHYEIANSPEEAISLAK		26	V20130429-03_FTMSms2hcd	70.430	170	195	41.1	1.9e-11	3.6e-14	1	27774.3	HUMAN	14-3-3 protein sigma
[22]		P31947	1433S_HUMAN	SFN	3	25.4	8.92	6.7e-16	454.2665	2	1.1	NLLSVAYK	NLLSVAYK		8	V20130429-03_FTMSms2hcd	35.950	42	49	23.5	8.8e-4	3.0e-6	7	27774.3	HUMAN	14-3-3 protein sigma
[22-1]	2	P63104	1433Z_HUMAN	YWHAZ	3	12.7	6.56	1.6e-11	774.8613	2	1.1	SVTEQGAELSNEER	SVTEQGAELSNEER		14	V20130429-03_FTMSms2hcd	21.211	28	41	47.5	1.6e-11	1.9e-14	1	27745.3	HUMAN	14-3-3 protein zeta/delta
[22-1]	2	P63104	1433Z_HUMAN	YWHAZ	3	12.7	6.56	1.6e-11	581.7917	2	-0.97	MDKNELVQK	Acetyl-M(Oxidation)DKNELVQK	Oxidation@1=7	9	V20130429-03_FTMSms2hcd	15.269	1	9	26.2	8.6e-6	1.3e-8	1	27745.3	HUMAN	14-3-3 protein zeta/delta
[22-1]	2	P63104	1433Z_HUMAN	YWHAZ	3	12.7	6.56	1.6e-11	454.2665	2	1.1	NLLSVAYK	NLLSVAYK		8	V20130429-03_FTMSms2hcd	35.950	42	49	23.5	8.8e-4	3.0e-6	7	27745.3	HUMAN	14-3-3 protein zeta/delta
[22-2]	0	P27348	1433T_HUMAN	YWHAQ	1	3.3	0.72	8.8e-4	454.2665	2	1.1	NLLSVAYK	NLLSVAYK		8	V20130429-03_FTMSms2hcd	35.950	42	49	23.5	8.8e-4	3.0e-6	7	27764.5	HUMAN	14-3-3 protein theta
[22-3]	0	P31946	1433B_HUMAN	YWHAB	1	3.3	0.72	8.8e-4	454.2665	2	1.1	NLLSVAYK	NLLSVAYK		8	V20130429-03_FTMSms2hcd	35.950	44	51	23.5	8.8e-4	3.0e-6	7	28082.6	HUMAN	14-3-3 protein beta/alpha
[22-4]	0	P61981	1433G_HUMAN	YWHAG	1	3.2	0.72	8.8e-4	454.2665	2	1.1	NLLSVAYK	NLLSVAYK		8	V20130429-03_FTMSms2hcd	35.950	43	50	23.5	8.8e-4	3.0e-6	7	28302.8	HUMAN	14-3-3 protein gamma
[22-5]	0	P62258	1433E_HUMAN	YWHAE	1	3.1	0.72	8.8e-4	454.2665	2	1.1	NLLSVAYK	NLLSVAYK		8	V20130429-03_FTMSms2hcd	35.950	43	50	23.5	8.8e-4	3.0e-6	7	29174.2	HUMAN	14-3-3 protein epsilon
[22-6]	0	Q04917	1433F_HUMAN	YWHAH	1	3.3	0.72	8.8e-4	454.2665	2	1.1	NLLSVAYK	NLLSVAYK		8	V20130429-03_FTMSms2hcd	35.950	43	50	23.5	8.8e-4	3.0e-6	7	28219.0	HUMAN	14-3-3 protein eta
[23]		P04792	HSPB1_HUMAN	HSPB1	4	25.9	5.14	7.2e-10	595.3132	3	1.4	VSLDVNHFAPDELTVK	VSLDVNHFAPDELTVK		16	V20130429-03_FTMSms2hcd	47.185	97	112	34.8	7.2e-10	1.1e-12	1	22782.7	HUMAN	Heat shock protein beta-1
[23]		P04792	HSPB1_HUMAN	HSPB1	4	25.9	5.14	7.2e-10	953.5013	2	1.9	LATQSNEITIPVTFESR	LATQSNEITIPVTFESR		17	V20130429-03_FTMSms2hcd	49.046	172	188	27.1	3.7e-8	5.6e-11	1	22782.7	HUMAN	Heat shock protein beta-1
[23]		P04792	HSPB1_HUMAN	HSPB1	4	25.9	5.14	7.2e-10	569.7601	2	-0.94	QLSSGVSEIR	Q(Gln->pyro-Glu)LS(Phospho)SGVSEIR	Gln->pyro-Glu@80;Phospho@82=12	10	V20130429-03_FTMSms2hcd	40.395	80	89	19.6	4.7e-7	6.9e-10	1	22782.7	HUMAN	Heat shock protein beta-1
[23]		P04792	HSPB1_HUMAN	HSPB1	4	25.9	5.14	7.2e-10	582.3100	2	-6.9	LFDQAFGLPR	LFDQAFGLPR		10	V20130429-03_FTMSms2hcd	48.951	28	37	33.5	1.7e-6	2.6e-9	1	22782.7	HUMAN	Heat shock protein beta-1
[24]		P37802	TAGL2_HUMAN	TAGLN2	3	22.1	7.22	9.3e-13	708.3069	2	1.6	GASQAGMTGYGMPR	GASQAGM(Oxidation)TGYGM(Oxidation)PR	Oxidation@189;Oxidation@194	14	V20130429-03_FTMSms2hcd	12.864	183	196	34.9	9.3e-13	1.6e-15	2	22391.7	HUMAN	Transgelin-2
[24]		P37802	TAGL2_HUMAN	TAGLN2	3	22.1	7.22	9.3e-13	1050.5216	2	3.6	YGINTTDIFQTVDLWEGK	YGINTTDIFQTVDLWEGK		18	V20130429-03_FTMSms2hcd	69.386	103	120	32.8	3.2e-8	3.3e-11	1	22391.7	HUMAN	Transgelin-2
[24]		P37802	TAGL2_HUMAN	TAGLN2	3	22.1	7.22	9.3e-13	602.3152	2	0.19	MANRGPAYGLSR	M(Met-loss+Acetyl)ANRGPAYGLSR	Met-loss+Acetyl@1	12	V20130429-03_FTMSms2hcd	23.072	1	12	41.2	2.3e-6	3.4e-9	1	22391.7	HUMAN	Transgelin-2
[24-1]	0	Q9UI15	TAGL3_HUMAN	TAGLN3	1	7.0	6.71	9.3e-13	708.3069	2	1.6	GASQAGMTGYGMPR	GASQAGM(Oxidation)TGYGM(Oxidation)PR	Oxidation@189;Oxidation@194	14	V20130429-03_FTMSms2hcd	12.864	183	196	34.9	9.3e-13	1.6e-15	2	22472.9	HUMAN	Transgelin-3
[25]		Q13268	DHRS2_HUMAN	DHRS2	3	16.7	8.30	4.8e-15	887.5106	3	1.4	RGAVILVSSIAAYNPVVALGVYNVSK	RGAVILVSSIAAYNPVVALGVYNVSK		26	V20130429-03_FTMSms2hcd	68.813	142	167	38.5	4.8e-15	6.8e-17	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[25]		Q13268	DHRS2_HUMAN	DHRS2	3	16.7	8.30	4.8e-15	835.4714	3	-5.0	GAVILVSSIAAYNPVVALGVYNVSK	GAVILVSSIAAYNPVVALGVYNVSK		25	V20130429-03_FTMSms2hcd	74.284	143	167	27.7	1.0e-10	6.5e-13	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[25]		Q13268	DHRS2_HUMAN	DHRS2	3	16.7	8.30	4.8e-15	833.9658	2	18	LQGEGLSVAGIVCHVGK	LQGEGLSVAGIVCHVGK		17	V20130429-03_FTMSms2hcd	34.617	58	74	13.8	0.096	2.5e-4	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[26]		P60174	TPIS_HUMAN	TPI1	3	18.5	6.60	6.9e-12	801.9478	2	-0.43	VVLAYEPVWAIGTGK	VVLAYEPVWAIGTGK		15	V20130429-03_FTMSms2hcd	55.936	198	212	38.5	6.9e-12	1.7e-14	1	30791.3	HUMAN	Triosephosphate isomerase
[26]		P60174	TPIS_HUMAN	TPI1	3	18.5	6.60	6.9e-12	477.7452	2	-0.094	FFVGGNWK	FFVGGNWK		8	V20130429-03_FTMSms2hcd	40.274	44	51	27.2	7.6e-9	1.1e-11	1	30791.3	HUMAN	Triosephosphate isomerase
[26]		P60174	TPIS_HUMAN	TPI1	3	18.5	6.60	6.9e-12	1053.2114	3	-6.9	ELASQPDVDGFLVGGASLKPEFVDIINAKQ	ELASQPDVDGFLVGGASLKPEFVDIINAKQ		30	V20130429-03_FTMSms2hcd	66.283	257	286	14.8	1.4e-4	2.4e-7	1	30791.3	HUMAN	Triosephosphate isomerase
[27]		P62081	RS7_HUMAN	RPS7	3	19.6	5.95	1.6e-10	631.6007	4	-0.30	TLTAVHDAILEDLVFPSEIVGKR	TLTAVHDAILEDLVFPSEIVGKR		23	V20130429-03_FTMSms2hcd	65.265	121	143	39.4	1.6e-10	6.6e-13	1	22127.0	HUMAN	40S ribosomal protein S7
[27]		P62081	RS7_HUMAN	RPS7	3	19.6	5.95	1.6e-10	789.7633	3	-2.2	TLTAVHDAILEDLVFPSEIVGK	TLTAVHDAILEDLVFPSEIVGK		22	V20130429-03_FTMSms2hcd	68.773	121	142	25.1	5.6e-10	1.4e-12	1	22127.0	HUMAN	40S ribosomal protein S7
[27]		P62081	RS7_HUMAN	RPS7	3	19.6	5.95	1.6e-10	892.4486	2	-0.11	LTGKDVNFEFPEFQL	LTGKDVNFEFPEFQL		15	V20130429-03_FTMSms2hcd	64.373	180	194	11.3	6.6e-4	7.8e-7	1	22127.0	HUMAN	40S ribosomal protein S7
[28]		P22392	NDKB_HUMAN	NME2	3	25.7	6.04	1.4e-10	672.8859	2	0.83	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-03_FTMSms2hcd	32.389	7	18	45.8	1.4e-10	3.7e-13	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[28]		P22392	NDKB_HUMAN	NME2	3	25.7	6.04	1.4e-10	601.3110	3	4.0	VMLGETNPADSKPGTIR	VM(Oxidation)LGETNPADSKPGTIR	Oxidation@90	17	V20130429-03_FTMSms2hcd	26.680	89	105	28.4	1.4e-8	1.8e-11	3	17298.2	HUMAN	Nucleoside diphosphate kinase B
[28]		P22392	NDKB_HUMAN	NME2	3	25.7	6.04	1.4e-10	588.3328	2	0.99	DRPFFPGLVK	DRPFFPGLVK		10	V20130429-03_FTMSms2hcd	42.993	57	66	21.9	6.2e-5	1.3e-7	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[28-1]	0	P15531	NDKA_HUMAN	NME1	2	19.1	6.04	1.4e-10	672.8859	2	0.83	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-03_FTMSms2hcd	32.389	7	18	45.8	1.4e-10	3.7e-13	2	17148.9	HUMAN	Nucleoside diphosphate kinase A
[28-1]	0	P15531	NDKA_HUMAN	NME1	2	19.1	6.04	1.4e-10	601.3110	3	4.0	VMLGETNPADSKPGTIR	VM(Oxidation)LGETNPADSKPGTIR	Oxidation@90	17	V20130429-03_FTMSms2hcd	26.680	89	105	28.4	1.4e-8	1.8e-11	3	17148.9	HUMAN	Nucleoside diphosphate kinase A
[28-2]	1	O60361	NDK8_HUMAN	NME2P1	3	27.0	3.93	1.4e-8	601.3110	3	4.0	VMLGETNPADSKPGTIR	VM(Oxidation)LGETNPADSKPGTIR	Oxidation@75	17	V20130429-03_FTMSms2hcd	26.680	74	90	28.4	1.4e-8	1.8e-11	3	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[28-2]	1	O60361	NDK8_HUMAN	NME2P1	3	27.0	3.93	1.4e-8	423.2245	3	1.6	FKPEELVDYK	FKPEELVDYK		10	V20130429-03_FTMSms2hcd	35.924	119	128	29.7	1.7e-8	2.5e-11	1	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[28-2]	1	O60361	NDK8_HUMAN	NME2P1	3	27.0	3.93	1.4e-8	588.3328	2	0.99	DRPFFPGLVK	DRPFFPGLVK		10	V20130429-03_FTMSms2hcd	42.993	42	51	21.9	6.2e-5	1.3e-7	2	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[29]		O60814	H2B1K_HUMAN	HIST1H2BK	3	26.2	6.82	5.0e-12	888.4085	2	0.34	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-03_FTMSms2hcd	55.106	59	73	52.6	5.0e-12	5.2e-15	14	13890.3	HUMAN	Histone H2B type 1-K
[29]		O60814	H2B1K_HUMAN	HIST1H2BK	3	26.2	6.82	5.0e-12	569.2776	2	1.5	ESYSVYVYK	ESYSVYVYK		9	V20130429-03_FTMSms2hcd	30.841	36	44	18.3	7.4e-6	1.1e-8	9	13890.3	HUMAN	Histone H2B type 1-K
[29]		O60814	H2B1K_HUMAN	HIST1H2BK	3	26.2	6.82	5.0e-12	477.3059	2	1.6	LLLPGELAK	LLLPGELAK		9	V20130429-03_FTMSms2hcd	41.798	101	109	33.5	2.6e-5	3.2e-7	15	13890.3	HUMAN	Histone H2B type 1-K
[29-1]	0	P57053	H2BFS_HUMAN	H2BFS	3	26.2	6.82	5.0e-12	888.4085	2	0.34	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-03_FTMSms2hcd	55.106	59	73	52.6	5.0e-12	5.2e-15	14	13944.3	HUMAN	Histone H2B type F-S
[29-1]	0	P57053	H2BFS_HUMAN	H2BFS	3	26.2	6.82	5.0e-12	569.2776	2	1.5	ESYSVYVYK	ESYSVYVYK		9	V20130429-03_FTMSms2hcd	30.841	36	44	18.3	7.4e-6	1.1e-8	9	13944.3	HUMAN	Histone H2B type F-S
[29-1]	0	P57053	H2BFS_HUMAN	H2BFS	3	26.2	6.82	5.0e-12	477.3059	2	1.6	LLLPGELAK	LLLPGELAK		9	V20130429-03_FTMSms2hcd	41.798	101	109	33.5	2.6e-5	3.2e-7	15	13944.3	HUMAN	Histone H2B type F-S
[29-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	3	26.2	6.82	5.0e-12	888.4085	2	0.34	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-03_FTMSms2hcd	55.106	59	73	52.6	5.0e-12	5.2e-15	14	13936.3	HUMAN	Histone H2B type 1-D
[29-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	3	26.2	6.82	5.0e-12	569.2776	2	1.5	ESYSVYVYK	ESYSVYVYK		9	V20130429-03_FTMSms2hcd	30.841	36	44	18.3	7.4e-6	1.1e-8	9	13936.3	HUMAN	Histone H2B type 1-D
[29-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	3	26.2	6.82	5.0e-12	477.3059	2	1.6	LLLPGELAK	LLLPGELAK		9	V20130429-03_FTMSms2hcd	41.798	101	109	33.5	2.6e-5	3.2e-7	15	13936.3	HUMAN	Histone H2B type 1-D
[29-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	3	26.2	6.82	5.0e-12	888.4085	2	0.34	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-03_FTMSms2hcd	55.106	59	73	52.6	5.0e-12	5.2e-15	14	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[29-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	3	26.2	6.82	5.0e-12	569.2776	2	1.5	ESYSVYVYK	ESYSVYVYK		9	V20130429-03_FTMSms2hcd	30.841	36	44	18.3	7.4e-6	1.1e-8	9	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[29-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	3	26.2	6.82	5.0e-12	477.3059	2	1.6	LLLPGELAK	LLLPGELAK		9	V20130429-03_FTMSms2hcd	41.798	101	109	33.5	2.6e-5	3.2e-7	15	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[29-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	3	26.2	6.82	5.0e-12	888.4085	2	0.34	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-03_FTMSms2hcd	55.106	59	73	52.6	5.0e-12	5.2e-15	14	13920.3	HUMAN	Histone H2B type 2-F
[29-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	3	26.2	6.82	5.0e-12	569.2776	2	1.5	ESYSVYVYK	ESYSVYVYK		9	V20130429-03_FTMSms2hcd	30.841	36	44	18.3	7.4e-6	1.1e-8	9	13920.3	HUMAN	Histone H2B type 2-F
[29-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	3	26.2	6.82	5.0e-12	477.3059	2	1.6	LLLPGELAK	LLLPGELAK		9	V20130429-03_FTMSms2hcd	41.798	101	109	33.5	2.6e-5	3.2e-7	15	13920.3	HUMAN	Histone H2B type 2-F
[29-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	3	26.2	6.82	5.0e-12	888.4085	2	0.34	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-03_FTMSms2hcd	55.106	59	73	52.6	5.0e-12	5.2e-15	14	13892.2	HUMAN	Histone H2B type 1-H
[29-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	3	26.2	6.82	5.0e-12	569.2776	2	1.5	ESYSVYVYK	ESYSVYVYK		9	V20130429-03_FTMSms2hcd	30.841	36	44	18.3	7.4e-6	1.1e-8	9	13892.2	HUMAN	Histone H2B type 1-H
[29-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	3	26.2	6.82	5.0e-12	477.3059	2	1.6	LLLPGELAK	LLLPGELAK		9	V20130429-03_FTMSms2hcd	41.798	101	109	33.5	2.6e-5	3.2e-7	15	13892.2	HUMAN	Histone H2B type 1-H
[29-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	3	26.2	6.82	5.0e-12	888.4085	2	0.34	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-03_FTMSms2hcd	55.106	59	73	52.6	5.0e-12	5.2e-15	14	13922.3	HUMAN	Histone H2B type 1-N
[29-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	3	26.2	6.82	5.0e-12	569.2776	2	1.5	ESYSVYVYK	ESYSVYVYK		9	V20130429-03_FTMSms2hcd	30.841	36	44	18.3	7.4e-6	1.1e-8	9	13922.3	HUMAN	Histone H2B type 1-N
[29-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	3	26.2	6.82	5.0e-12	477.3059	2	1.6	LLLPGELAK	LLLPGELAK		9	V20130429-03_FTMSms2hcd	41.798	101	109	33.5	2.6e-5	3.2e-7	15	13922.3	HUMAN	Histone H2B type 1-N
[29-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	3	26.2	6.82	5.0e-12	888.4085	2	0.34	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-03_FTMSms2hcd	55.106	59	73	52.6	5.0e-12	5.2e-15	14	13989.4	HUMAN	Histone H2B type 1-M
[29-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	3	26.2	6.82	5.0e-12	569.2776	2	1.5	ESYSVYVYK	ESYSVYVYK		9	V20130429-03_FTMSms2hcd	30.841	36	44	18.3	7.4e-6	1.1e-8	9	13989.4	HUMAN	Histone H2B type 1-M
[29-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	3	26.2	6.82	5.0e-12	477.3059	2	1.6	LLLPGELAK	LLLPGELAK		9	V20130429-03_FTMSms2hcd	41.798	101	109	33.5	2.6e-5	3.2e-7	15	13989.4	HUMAN	Histone H2B type 1-M
[29-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	3	26.2	6.82	5.0e-12	888.4085	2	0.34	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-03_FTMSms2hcd	55.106	59	73	52.6	5.0e-12	5.2e-15	14	13952.3	HUMAN	Histone H2B type 1-L
[29-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	3	26.2	6.82	5.0e-12	569.2776	2	1.5	ESYSVYVYK	ESYSVYVYK		9	V20130429-03_FTMSms2hcd	30.841	36	44	18.3	7.4e-6	1.1e-8	9	13952.3	HUMAN	Histone H2B type 1-L
[29-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	3	26.2	6.82	5.0e-12	477.3059	2	1.6	LLLPGELAK	LLLPGELAK		9	V20130429-03_FTMSms2hcd	41.798	101	109	33.5	2.6e-5	3.2e-7	15	13952.3	HUMAN	Histone H2B type 1-L
[29-9]	0	P06899	H2B1J_HUMAN	HIST1H2BJ	2	19.0	6.82	5.0e-12	888.4085	2	0.34	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-03_FTMSms2hcd	55.106	59	73	52.6	5.0e-12	5.2e-15	14	13904.3	HUMAN	Histone H2B type 1-J
[29-9]	0	P06899	H2B1J_HUMAN	HIST1H2BJ	2	19.0	6.82	5.0e-12	477.3059	2	1.6	LLLPGELAK	LLLPGELAK		9	V20130429-03_FTMSms2hcd	41.798	101	109	33.5	2.6e-5	3.2e-7	15	13904.3	HUMAN	Histone H2B type 1-J
[29-10]	0	P23527	H2B1O_HUMAN	HIST1H2BO	2	19.0	6.82	5.0e-12	888.4085	2	0.34	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-03_FTMSms2hcd	55.106	59	73	52.6	5.0e-12	5.2e-15	14	13906.3	HUMAN	Histone H2B type 1-O
[29-10]	0	P23527	H2B1O_HUMAN	HIST1H2BO	2	19.0	6.82	5.0e-12	477.3059	2	1.6	LLLPGELAK	LLLPGELAK		9	V20130429-03_FTMSms2hcd	41.798	101	109	33.5	2.6e-5	3.2e-7	15	13906.3	HUMAN	Histone H2B type 1-O
[29-11]	0	P33778	H2B1B_HUMAN	HIST1H2BB	2	19.0	6.82	5.0e-12	888.4085	2	0.34	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-03_FTMSms2hcd	55.106	59	73	52.6	5.0e-12	5.2e-15	14	13950.3	HUMAN	Histone H2B type 1-B
[29-11]	0	P33778	H2B1B_HUMAN	HIST1H2BB	2	19.0	6.82	5.0e-12	477.3059	2	1.6	LLLPGELAK	LLLPGELAK		9	V20130429-03_FTMSms2hcd	41.798	101	109	33.5	2.6e-5	3.2e-7	15	13950.3	HUMAN	Histone H2B type 1-B
[29-12]	0	Q16778	H2B2E_HUMAN	HIST2H2BE	2	19.0	6.82	5.0e-12	888.4085	2	0.34	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-03_FTMSms2hcd	55.106	59	73	52.6	5.0e-12	5.2e-15	14	13920.3	HUMAN	Histone H2B type 2-E
[29-12]	0	Q16778	H2B2E_HUMAN	HIST2H2BE	2	19.0	6.82	5.0e-12	477.3059	2	1.6	LLLPGELAK	LLLPGELAK		9	V20130429-03_FTMSms2hcd	41.798	101	109	33.5	2.6e-5	3.2e-7	15	13920.3	HUMAN	Histone H2B type 2-E
[29-13]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	2	19.0	6.82	5.0e-12	888.4085	2	0.34	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-03_FTMSms2hcd	55.106	59	73	52.6	5.0e-12	5.2e-15	14	13908.2	HUMAN	Histone H2B type 3-B
[29-13]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	2	19.0	6.82	5.0e-12	477.3059	2	1.6	LLLPGELAK	LLLPGELAK		9	V20130429-03_FTMSms2hcd	41.798	101	109	33.5	2.6e-5	3.2e-7	15	13908.2	HUMAN	Histone H2B type 3-B
[29-14]	0	Q96A08	H2B1A_HUMAN	HIST1H2BA	1	7.1	2.54	2.6e-5	477.3059	2	1.6	LLLPGELAK	LLLPGELAK		9	V20130429-03_FTMSms2hcd	41.798	102	110	33.5	2.6e-5	3.2e-7	15	14167.6	HUMAN	Histone H2B type 1-A
[30]		P35579	MYH9_HUMAN	MYH9	3	2.2	6.58	1.7e-12	650.6694	3	0.49	LQQELDDLLVDLDHQR	LQQELDDLLVDLDHQR		16	V20130429-03_FTMSms2hcd	58.268	1418	1433	35.1	1.7e-12	2.3e-15	1	226534.2	HUMAN	Myosin-9
[30]		P35579	MYH9_HUMAN	MYH9	3	2.2	6.58	1.7e-12	539.0026	3	-0.55	VISGVLQLGNIVFKK	VISGVLQLGNIVFKK		15	V20130429-03_FTMSms2hcd	58.242	342	356	25.6	8.6e-11	2.1e-12	1	226534.2	HUMAN	Myosin-9
[30]		P35579	MYH9_HUMAN	MYH9	3	2.2	6.58	1.7e-12	783.3714	2	3.4	YAEERDRAEAEAR	YAEERDRAEAEAR		13	V20130429-03_FTMSms2hcd	11.069	1460	1472	11.5	0.020	2.4e-5	2	226534.2	HUMAN	Myosin-9
[31]		P25705	ATPA_HUMAN	ATP5A1	2	5.2	6.72	7.8e-12	812.9491	2	0.28	TGAIVDVPVGEELLGR	TGAIVDVPVGEELLGR		16	V20130429-03_FTMSms2hcd	54.330	134	149	48.6	7.8e-12	1.8e-14	1	59751.1	HUMAN	ATP synthase subunit alpha, mitochondrial
[31]		P25705	ATPA_HUMAN	ATP5A1	2	5.2	6.72	7.8e-12	720.3406	2	3.9	TGTAEMSSILEER	TGTAEM(Oxidation)SSILEER	Oxidation@51	13	V20130429-03_FTMSms2hcd	26.495	46	58	42.6	2.0e-11	2.5e-14	1	59751.1	HUMAN	ATP synthase subunit alpha, mitochondrial
[32]		P78371	TCPB_HUMAN	CCT2	3	9.3	5.97	3.0e-12	759.4523	2	2.3	LTSFIGAIAIGDLVK	LTSFIGAIAIGDLVK		15	V20130429-03_FTMSms2hcd	67.908	26	40	30.3	3.0e-12	2.3e-14	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[32]		P78371	TCPB_HUMAN	CCT2	3	9.3	5.97	3.0e-12	651.3763	2	-0.80	MASLSLAPVNIFK	M(Met-loss+Acetyl)ASLSLAPVNIFK	Met-loss+Acetyl@1	13	V20130429-03_FTMSms2hcd	65.921	1	13	28.3	3.0e-8	8.1e-11	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[32]		P78371	TCPB_HUMAN	CCT2	3	9.3	5.97	3.0e-12	763.3923	3	0.32	VQDDEVGDGTTSVTVLAAELLR	VQDDEVGDGTTSVTVLAAELLR		22	V20130429-03_FTMSms2hcd	68.705	90	111	17.9	1.5e-6	1.8e-9	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[33]		P30101	PDIA3_HUMAN	PDIA3	2	9.9	8.44	5.0e-15	859.1072	3	1.2	TFSHELSDFGLESTAGEIPVVAIR	TFSHELSDFGLESTAGEIPVVAIR		24	V20130429-03_FTMSms2hcd	60.588	306	329	47.8	5.0e-15	6.3e-18	1	56782.9	HUMAN	Protein disulfide-isomerase A3
[33]		P30101	PDIA3_HUMAN	PDIA3	2	9.9	8.44	5.0e-15	980.1262	3	-4.8	FISDKDASIVGFFDDSFSEAHSEFLK	FISDKDASIVGFFDDSFSEAHSEFLK		26	V20130429-03_FTMSms2hcd	68.344	148	173	15.8	4.6e-7	4.3e-10	1	56782.9	HUMAN	Protein disulfide-isomerase A3
[34]		P11586	C1TC_HUMAN	MTHFD1	3	3.7	5.61	8.9e-10	689.8364	2	-3.0	TDTESELDLISR	TDTESELDLISR		12	V20130429-03_FTMSms2hcd	39.119	761	772	39.0	8.9e-10	1.2e-12	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[34]		P11586	C1TC_HUMAN	MTHFD1	3	3.7	5.61	8.9e-10	752.8607	2	1.0	TDPTTLTDEEINR	TDPTTLTDEEINR		13	V20130429-03_FTMSms2hcd	30.182	505	517	48.5	9.5e-9	1.2e-11	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[34]		P11586	C1TC_HUMAN	MTHFD1	3	3.7	5.61	8.9e-10	456.7605	2	-1.3	MAPAEILNGK	M(Met-loss)APAEILNGK	Met-loss@1	10	V20130429-03_FTMSms2hcd	44.148	1	10	11.6	0.034	1.5e-4	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[35]		P16403	H12_HUMAN	HIST1H1C	2	16.9	6.86	4.3e-12	789.8981	2	1.2	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-03_FTMSms2hcd	21.607	65	79	65.4	4.3e-12	5.5e-15	5	21364.9	HUMAN	Histone H1.2
[35]		P16403	H12_HUMAN	HIST1H1C	2	16.9	6.86	4.3e-12	958.5145	2	4.9	MSETAPAAPAAAPPAEKAPVK	M(Met-loss+Acetyl)SETAPAAPAAAPPAEKAPVK	Met-loss+Acetyl@1	21	V20130429-03_FTMSms2hcd	26.853	1	21	21.8	7.9e-8	1.5e-10	1	21364.9	HUMAN	Histone H1.2
[35-1]	0	P10412	H14_HUMAN	HIST1H1E	1	6.8	6.86	4.3e-12	789.8981	2	1.2	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-03_FTMSms2hcd	21.607	65	79	65.4	4.3e-12	5.5e-15	5	21865.4	HUMAN	Histone H1.4
[35-2]	0	P16402	H13_HUMAN	HIST1H1D	1	6.8	6.86	4.3e-12	789.8981	2	1.2	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-03_FTMSms2hcd	21.607	66	80	65.4	4.3e-12	5.5e-15	5	22350.1	HUMAN	Histone H1.3
[35-3]	0	P22492	H1T_HUMAN	HIST1H1T	1	7.2	6.86	4.3e-12	789.8981	2	1.2	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-03_FTMSms2hcd	21.607	69	83	65.4	4.3e-12	5.5e-15	5	22019.2	HUMAN	Histone H1t
[35-4]	0	Q02539	H11_HUMAN	HIST1H1A	1	7.0	6.86	4.3e-12	789.8981	2	1.2	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-03_FTMSms2hcd	21.607	68	82	65.4	4.3e-12	5.5e-15	5	21842.3	HUMAN	Histone H1.1
[36]		Q15365	PCBP1_HUMAN	PCBP1	2	9.6	7.08	1.1e-12	1089.1021	2	2.1	QVTITGSAASISLAQYLINAR	QVTITGSAASISLAQYLINAR		21	V20130429-03_FTMSms2hcd	64.131	326	346	39.1	1.1e-12	3.8e-15	1	37498.2	HUMAN	Poly(rC)-binding protein 1
[36]		Q15365	PCBP1_HUMAN	PCBP1	2	9.6	7.08	1.1e-12	694.9106	2	-0.62	IITLTGPTNAIFK	IITLTGPTNAIFK		13	V20130429-03_FTMSms2hcd	52.111	58	70	28.4	1.6e-7	6.7e-10	1	37498.2	HUMAN	Poly(rC)-binding protein 1
[37]		P20700	LMNB1_HUMAN	LMNB1	2	6.8	8.94	5.9e-16	1137.8612	3	-0.59	TTIPEEEEEEEEAAGVVVEEELFHQQGTPR	TTIPEEEEEEEEAAGVVVEEELFHQQGTPR		30	V20130429-03_FTMSms2hcd	61.308	548	577	50.2	5.9e-16	5.8e-19	1	66408.9	HUMAN	Lamin-B1
[37]		P20700	LMNB1_HUMAN	LMNB1	2	6.8	8.94	5.9e-16	455.2609	2	-0.79	MATATPVPPR	M(Met-loss)ATATPVPPR	Met-loss@1	10	V20130429-03_FTMSms2hcd	10.011	1	10	13.4	0.0056	1.5e-5	1	66408.9	HUMAN	Lamin-B1
[38]		P23528	COF1_HUMAN	CFL1	2	24.7	6.77	6.3e-12	1021.5407	3	4.7	NIILEEGKEILVGDVGQTVDDPYATFVK	NIILEEGKEILVGDVGQTVDDPYATFVK		28	V20130429-03_FTMSms2hcd	64.683	46	73	44.4	6.3e-12	1.4e-14	1	18502.7	HUMAN	Cofilin-1
[38]		P23528	COF1_HUMAN	CFL1	2	24.7	6.77	6.3e-12	572.8148	2	1.3	MASGVAVSDGVIK	M(Met-loss+Acetyl)ASGVAVSDGVIK	Met-loss+Acetyl@1	13	V20130429-03_FTMSms2hcd	35.885	1	13	33.5	5.7e-7	9.9e-10	1	18502.7	HUMAN	Cofilin-1
[39]		P61978	HNRPK_HUMAN	HNRNPK	2	6.7	6.50	1.5e-11	615.0311	3	0.049	ILSISADIETIGEILKK	ILSISADIETIGEILKK		17	V20130429-03_FTMSms2hcd	71.396	87	103	39.4	1.5e-11	1.7e-13	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[39]		P61978	HNRPK_HUMAN	HNRNPK	2	6.7	6.50	1.5e-11	518.6468	3	-0.18	IILDLISESPIKGR	IILDLISESPIKGR		14	V20130429-03_FTMSms2hcd	52.085	208	221	38.2	4.5e-7	3.6e-9	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[40]		P07195	LDHB_HUMAN	LDHB	2	6.9	6.82	5.0e-12	755.8909	2	-0.16	IVADKDYSVTANSK	IVADKDYSVTANSK		14	V20130429-03_FTMSms2hcd	19.526	78	91	47.8	5.0e-12	6.8e-15	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[40]		P07195	LDHB_HUMAN	LDHB	2	6.9	6.82	5.0e-12	480.2825	2	5.9	GLTSVINQK	GLTSVINQK		9	V20130429-03_FTMSms2hcd	26.774	300	308	31.6	7.3e-6	1.6e-8	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[41]		P22626	ROA2_HUMAN	HNRNPA2B1	3	15.0	4.51	1.1e-8	956.4687	3	1.0	LFIGGLSFETTEESLRNYYEQWGK	LFIGGLSFETTEESLRNYYEQWGK		24	V20130429-03_FTMSms2hcd	69.830	23	46	34.9	1.1e-8	1.2e-11	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[41]		P22626	ROA2_HUMAN	HNRNPA2B1	3	15.0	4.51	1.1e-8	529.2977	2	-0.64	TLETVPLER	TLETVPLER		9	V20130429-03_FTMSms2hcd	30.555	4	12	20.1	2.8e-5	6.0e-8	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[41]		P22626	ROA2_HUMAN	HNRNPA2B1	3	15.0	4.51	1.1e-8	759.7242	3	1.3	GFGFVTFDDHDPVDKIVLQK	GFGFVTFDDHDPVDKIVLQK		20	V20130429-03_FTMSms2hcd	55.841	154	173	22.0	9.4e-5	1.2e-7	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[42]		P05787	K2C8_HUMAN	KRT8	2	11.6	7.63	1.6e-13	1242.5797	3	1.2	TTSGYAGGLSSAYGGLTSPGLSYSLGSSFGSGAGSSSFSR	TTSGYAGGLSSAYGGLTSPGLSYSLGSSFGSGAGSSSFSR		40	V20130429-03_FTMSms2hcd	59.022	415	454	43.4	1.6e-13	1.7e-16	1	53704.7	HUMAN	Keratin, type II cytoskeletal 8
[42]		P05787	K2C8_HUMAN	KRT8	2	11.6	7.63	1.6e-13	971.4738	2	9.3	KDVDEAYMNKVELESR	KDVDEAYM(Oxidation)NKVELESR	Oxidation@205	16	V20130429-03_FTMSms2hcd	25.503	198	213	10.7	0.028	3.1e-5	1	53704.7	HUMAN	Keratin, type II cytoskeletal 8
[43]		P31949	S10AB_HUMAN	S100A11	2	23.8	4.77	6.6e-9	933.4517	2	-1.5	TEFLSFMNTELAAFTK	TEFLSFM(Oxidation)NTELAAFTK	Oxidation@43	16	V20130429-03_FTMSms2hcd	60.654	37	52	36.3	6.6e-9	7.2e-12	1	11740.6	HUMAN	Protein S100-A11
[43]		P31949	S10AB_HUMAN	S100A11	2	23.8	4.77	6.6e-9	510.2539	2	0.14	ISSPTETER	ISSPTETER		9	V20130429-03_FTMSms2hcd	13.119	4	12	35.8	5.4e-7	8.8e-10	1	11740.6	HUMAN	Protein S100-A11
[44]		P62158	CALM_HUMAN	CALM1	1	20.8	8.29	9.7e-15	1130.5431	3	-3.6	MADQLTEEQIAEFKEAFSLFDKDGDGTITTK	M(Met-loss+Acetyl)ADQLTEEQIAEFKEAFSLFDKDGDGTITTK	Met-loss+Acetyl@1	31	V20130429-03_FTMSms2hcd	73.032	1	31	44.8	9.7e-15	9.7e-18	1	16837.7	HUMAN	Calmodulin
[45]		Q08211	DHX9_HUMAN	DHX9	1	1.3	7.54	9.0e-14	1025.5146	2	-1.0	TTQVPQFILDDFIQNDR	TTQVPQFILDDFIQNDR		17	V20130429-03_FTMSms2hcd	64.614	418	434	37.8	9.0e-14	1.1e-16	1	140959.7	HUMAN	ATP-dependent RNA helicase A
[46]		P68431	H31_HUMAN	HIST1H3A	2	14.7	4.00	4.2e-7	516.7979	2	-6.2	YRPGTVALR	YRPGTVALR		9	V20130429-03_FTMSms2hcd	20.722	42	50	38.4	4.2e-7	8.8e-10	5	15404.2	HUMAN	Histone H3.1
[46]		P68431	H31_HUMAN	HIST1H3A	2	14.7	4.00	4.2e-7	445.9020	3	0.85	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-03_FTMSms2hcd	31.195	74	84	23.8	4.0e-6	6.0e-9	4	15404.2	HUMAN	Histone H3.1
[46-1]	0	P84243	H33_HUMAN	H3F3A	2	14.7	4.00	4.2e-7	516.7979	2	-6.2	YRPGTVALR	YRPGTVALR		9	V20130429-03_FTMSms2hcd	20.722	42	50	38.4	4.2e-7	8.8e-10	5	15328.0	HUMAN	Histone H3.3
[46-1]	0	P84243	H33_HUMAN	H3F3A	2	14.7	4.00	4.2e-7	445.9020	3	0.85	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-03_FTMSms2hcd	31.195	74	84	23.8	4.0e-6	6.0e-9	4	15328.0	HUMAN	Histone H3.3
[46-2]	0	Q16695	H31T_HUMAN	HIST3H3	2	14.7	4.00	4.2e-7	516.7979	2	-6.2	YRPGTVALR	YRPGTVALR		9	V20130429-03_FTMSms2hcd	20.722	42	50	38.4	4.2e-7	8.8e-10	5	15508.4	HUMAN	Histone H3.1t
[46-2]	0	Q16695	H31T_HUMAN	HIST3H3	2	14.7	4.00	4.2e-7	445.9020	3	0.85	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-03_FTMSms2hcd	31.195	74	84	23.8	4.0e-6	6.0e-9	4	15508.4	HUMAN	Histone H3.1t
[46-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	2	14.7	4.00	4.2e-7	516.7979	2	-6.2	YRPGTVALR	YRPGTVALR		9	V20130429-03_FTMSms2hcd	20.722	42	50	38.4	4.2e-7	8.8e-10	5	15388.2	HUMAN	Histone H3.2
[46-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	2	14.7	4.00	4.2e-7	445.9020	3	0.85	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-03_FTMSms2hcd	31.195	74	84	23.8	4.0e-6	6.0e-9	4	15388.2	HUMAN	Histone H3.2
[46-4]	0	Q6NXT2	H3C_HUMAN	H3F3C	1	6.7	4.00	4.2e-7	516.7979	2	-6.2	YRPGTVALR	YRPGTVALR		9	V20130429-03_FTMSms2hcd	20.722	41	49	38.4	4.2e-7	8.8e-10	5	15213.9	HUMAN	Histone H3.3C
[47]		Q96DA6	TIM14_HUMAN	DNAJC19	1	17.2	7.20	1.4e-13	887.5005	2	4.5	MASTVVAVGLTIAAAGFAGR	M(Met-loss+Acetyl)ASTVVAVGLTIAAAGFAGR	Met-loss+Acetyl@1	20	V20130429-03_FTMSms2hcd	78.132	1	20	35.5	1.4e-13	5.2e-16	1	12498.7	HUMAN	Mitochondrial import inner membrane translocase subunit TIM14
[48]		P00338	LDHA_HUMAN	LDHA	2	5.4	3.51	9.2e-8	567.7847	2	-1.4	VTLTSEEEAR	VTLTSEEEAR		10	V20130429-03_FTMSms2hcd	19.488	306	315	29.9	9.2e-8	1.4e-10	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[48]		P00338	LDHA_HUMAN	LDHA	2	5.4	3.51	9.2e-8	465.2946	2	0.063	FIIPNVVK	FIIPNVVK		8	V20130429-03_FTMSms2hcd	45.529	119	126	28.4	1.2e-7	5.0e-10	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[49]		P05091	ALDH2_HUMAN	ALDH2	1	2.7	6.91	1.7e-13	895.4172	2	-0.45	TFVQEDIYDEFVER	TFVQEDIYDEFVER		14	V20130429-03_FTMSms2hcd	54.783	325	338	33.0	1.7e-13	2.0e-16	1	56381.8	HUMAN	Aldehyde dehydrogenase, mitochondrial
[50]		Q9Y3B8	ORN_HUMAN	REXO2	1	8.9	6.38	1.1e-11	820.4314	3	-0.82	AVKESTITLQQAEYEFLSFVR	AVKESTITLQQAEYEFLSFVR		21	V20130429-03_FTMSms2hcd	72.761	109	129	37.5	1.1e-11	2.0e-14	1	26833.0	HUMAN	Oligoribonuclease, mitochondrial
[51]		P10768	ESTD_HUMAN	ESD	1	7.4	6.31	8.0e-12	863.7492	3	-3.0	LQEGYDHSYYFIATFITDHIR	LQEGYDHSYYFIATFITDHIR		21	V20130429-03_FTMSms2hcd	68.067	254	274	36.0	8.0e-12	8.2e-15	1	31463.1	HUMAN	S-formylglutathione hydrolase
[52]		P25205	MCM3_HUMAN	MCM3	1	2.6	6.27	3.7e-11	820.4174	3	1.5	TVDLQDAEEAVELVQYAYFKK	TVDLQDAEEAVELVQYAYFKK		21	V20130429-03_FTMSms2hcd	69.640	636	656	39.1	3.7e-11	4.8e-14	1	90981.6	HUMAN	DNA replication licensing factor MCM3
[53]		P09211	GSTP1_HUMAN	GSTP1	1	12.4	6.26	5.4e-11	1003.1635	3	1.4	MLLADQGQSWKEEVVTVETWQEGSLK	M(Oxidation)LLADQGQSWKEEVVTVETWQEGSLK	Oxidation@20	26	V20130429-03_FTMSms2hcd	57.828	20	45	41.8	5.4e-11	5.8e-14	1	23356.0	HUMAN	Glutathione S-transferase P
[54]		P06753	TPM3_HUMAN	TPM3	1	4.6	6.08	1.2e-10	738.8424	2	-2.5	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-03_FTMSms2hcd	13.978	113	125	52.9	1.2e-10	1.4e-13	4	32819.1	HUMAN	Tropomyosin alpha-3 chain
[54-1]	0	P07951	TPM2_HUMAN	TPM2	1	4.6	6.08	1.2e-10	738.8424	2	-2.5	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-03_FTMSms2hcd	13.978	113	125	52.9	1.2e-10	1.4e-13	4	32851.0	HUMAN	Tropomyosin beta chain
[54-2]	0	P09493	TPM1_HUMAN	TPM1	1	4.6	6.08	1.2e-10	738.8424	2	-2.5	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-03_FTMSms2hcd	13.978	113	125	52.9	1.2e-10	1.4e-13	4	32708.8	HUMAN	Tropomyosin alpha-1 chain
[54-3]	0	P67936	TPM4_HUMAN	TPM4	1	5.2	6.08	1.2e-10	738.8424	2	-2.5	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-03_FTMSms2hcd	13.978	77	89	52.9	1.2e-10	1.4e-13	4	28522.0	HUMAN	Tropomyosin alpha-4 chain
[55]		P14174	MIF_HUMAN	MIF	2	18.3	3.61	1.2e-6	652.3400	2	-7.7	MPMFIVNTNVPR	M(Met-loss)PM(Oxidation)FIVNTNVPR	Met-loss@1;Oxidation@3	12	V20130429-03_FTMSms2hcd	37.071	1	12	27.1	1.2e-6	1.7e-9	1	12476.4	HUMAN	Macrophage migration inhibitory factor
[55]		P14174	MIF_HUMAN	MIF	2	18.3	3.61	1.2e-6	494.2863	2	-0.24	LLCGLLAER	LLCGLLAER		9	V20130429-03_FTMSms2hcd	47.090	79	87	37.0	1.7e-4	3.0e-7	1	12476.4	HUMAN	Macrophage migration inhibitory factor
[56]		P13639	EF2_HUMAN	EEF2	1	2.4	6.05	6.4e-11	785.0803	3	3.3	GVQYLNEIKDSVVAGFQWATK	GVQYLNEIKDSVVAGFQWATK		21	V20130429-03_FTMSms2hcd	68.641	668	688	38.3	6.4e-11	1.1e-13	1	95339.0	HUMAN	Elongation factor 2
[57]		P62701	RS4X_HUMAN	RPS4X	3	11.4	3.16	3.3e-7	608.8600	2	0.41	ECLPLIIFLR	ECLPLIIFLR		10	V20130429-03_FTMSms2hcd	73.339	40	49	23.9	3.3e-7	1.1e-9	1	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[57]		P62701	RS4X_HUMAN	RPS4X	3	11.4	3.16	3.3e-7	495.8071	2	8.8	LSNIFVIGK	LSNIFVIGK		9	V20130429-03_FTMSms2hcd	45.072	222	230	29.4	9.6e-6	7.1e-8	1	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[57]		P62701	RS4X_HUMAN	RPS4X	3	11.4	3.16	3.3e-7	405.8914	3	0.30	GIPHLVTHDAR	GIPHLVTHDAR		11	V20130429-03_FTMSms2hcd	16.793	135	145	12.5	0.081	1.3e-4	3	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[58]		P63313	TYB10_HUMAN	TMSB10	1	34.1	5.73	5.2e-10	791.3601	2	1.8	MADKPDMGEIASFDK	M(Met-loss+Acetyl)ADKPDM(Oxidation)GEIASFDK	Met-loss+Acetyl@1;Oxidation@7	15	V20130429-03_FTMSms2hcd	31.302	1	15	44.0	5.2e-10	6.8e-13	1	5025.7	HUMAN	Thymosin beta-10
[59]		P13693	TCTP_HUMAN	TPT1	1	27.3	5.63	1.2e-11	1219.0728	4	2.1	TEGNIDDSLIGGNASAEGPEGEGTESTVITGVDIVMNHHLQETSFTK	TEGNIDDSLIGGNASAEGPEGEGTESTVITGVDIVM(Oxidation)NHHLQETSFTK	Oxidation@74	47	V20130429-03_FTMSms2hcd	55.586	39	85	30.2	1.2e-11	2.0e-14	1	19595.5	HUMAN	Translationally-controlled tumor protein
[60]		P06732	KCRM_HUMAN	CKM	2	11.8	4.57	7.0e-10	1254.6322	3	-0.20	GTGGVDTAAVGSVFDVSNADRLGSSEVEQVQLVVDGVK	GTGGVDTAAVGSVFDVSNADRLGSSEVEQVQLVVDGVK		38	V20130429-03_FTMSms2hcd	67.236	321	358	24.5	7.0e-10	1.1e-12	1	43101.5	HUMAN	Creatine kinase M-type
[60]		P06732	KCRM_HUMAN	CKM	2	11.8	4.57	7.0e-10	454.2483	2	1.1	FEEILTR	FEEILTR		7	V20130429-03_FTMSms2hcd	30.379	308	314	29.1	0.0038	7.4e-6	1	43101.5	HUMAN	Creatine kinase M-type
[61]		P38646	GRP75_HUMAN	HSPA9	1	2.1	5.28	2.9e-10	725.8636	2	1.8	TTPSVVAFTADGER	TTPSVVAFTADGER		14	V20130429-03_FTMSms2hcd	36.170	86	99	34.1	2.9e-10	3.8e-13	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[62]		P0CG47	UBB_HUMAN	UBB	1	7.0	5.18	3.7e-10	894.4678	2	0.57	TITLEVEPSDTIENVK	TITLEVEPSDTIENVK		16	V20130429-03_FTMSms2hcd	44.925	12	27	33.6	3.7e-10	4.9e-13	4	25761.8	HUMAN	Polyubiquitin-B
[62-1]	0	P0CG48	UBC_HUMAN	UBC	1	2.3	5.18	3.7e-10	894.4678	2	0.57	TITLEVEPSDTIENVK	TITLEVEPSDTIENVK		16	V20130429-03_FTMSms2hcd	44.925	12	27	33.6	3.7e-10	4.9e-13	4	77029.2	HUMAN	Polyubiquitin-C
[62-2]	0	P62979	RS27A_HUMAN	RPS27A	1	10.3	5.18	3.7e-10	894.4678	2	0.57	TITLEVEPSDTIENVK	TITLEVEPSDTIENVK		16	V20130429-03_FTMSms2hcd	44.925	12	27	33.6	3.7e-10	4.9e-13	4	17965.1	HUMAN	Ubiquitin-40S ribosomal protein S27a
[62-3]	0	P62987	RL40_HUMAN	UBA52	1	12.5	5.18	3.7e-10	894.4678	2	0.57	TITLEVEPSDTIENVK	TITLEVEPSDTIENVK		16	V20130429-03_FTMSms2hcd	44.925	12	27	33.6	3.7e-10	4.9e-13	4	14728.5	HUMAN	Ubiquitin-60S ribosomal protein L40
[63]		Q15084	PDIA6_HUMAN	PDIA6	1	3.2	4.97	1.4e-8	693.8836	2	0.87	TGEAIVDAALSALR	TGEAIVDAALSALR		14	V20130429-03_FTMSms2hcd	61.361	119	132	40.5	1.4e-8	2.6e-11	1	48121.7	HUMAN	Protein disulfide-isomerase A6
[64]		Q14116	IL18_HUMAN	IL18	1	14.0	4.93	2.7e-10	1072.5051	3	2.0	FIDNTLYFIAEDDENLESDYFGKLESK	FIDNTLYFIAEDDENLESDYFGKLESK		27	V20130429-03_FTMSms2hcd	69.855	18	44	30.4	2.7e-10	2.6e-13	1	22326.4	HUMAN	Interleukin-18
[65]		P26599	PTBP1_HUMAN	PTBP1	1	3.4	4.86	4.8e-10	680.3720	3	2.7	VTPQSLFILFGVYGDVQR	VTPQSLFILFGVYGDVQR		18	V20130429-03_FTMSms2hcd	75.041	349	366	31.1	4.8e-10	1.1e-12	1	57221.8	HUMAN	Polypyrimidine tract-binding protein 1
[66]		P23284	PPIB_HUMAN	PPIB	1	6.0	4.85	2.3e-8	682.8574	2	1.4	TVDNFVALATGEK	TVDNFVALATGEK		13	V20130429-03_FTMSms2hcd	45.701	72	84	42.1	2.3e-8	3.1e-11	1	23742.7	HUMAN	Peptidyl-prolyl cis-trans isomerase B
[67]		O60812	HNRCL_HUMAN	HNRNPCL1	1	4.1	4.45	9.1e-9	658.9005	2	0.057	VFIGNLNTLVVK	VFIGNLNTLVVK		12	V20130429-03_FTMSms2hcd	52.125	18	29	33.9	9.1e-9	7.6e-11	2	32142.6	HUMAN	Heterogeneous nuclear ribonucleoprotein C-like 1
[67-1]	0	P07910	HNRPC_HUMAN	HNRNPC	1	3.9	4.45	9.1e-9	658.9005	2	0.057	VFIGNLNTLVVK	VFIGNLNTLVVK		12	V20130429-03_FTMSms2hcd	52.125	18	29	33.9	9.1e-9	7.6e-11	2	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[68]		P43487	RANG_HUMAN	RANBP1	1	5.5	4.32	4.9e-8	691.3218	2	-0.44	TLEEDEEELFK	TLEEDEEELFK		11	V20130429-03_FTMSms2hcd	44.551	40	50	36.5	4.9e-8	6.9e-11	1	23310.3	HUMAN	Ran-specific GTPase-activating protein
[69]		Q8NC51	PAIRB_HUMAN	SERBP1	1	5.1	4.16	4.9e-10	1052.4915	2	1.9	TDKSSASAPDVDDPEAFPALA	TDKSSASAPDVDDPEAFPALA		21	V20130429-03_FTMSms2hcd	46.254	388	408	24.1	4.9e-10	5.2e-13	1	44965.7	HUMAN	Plasminogen activator inhibitor 1 RNA-binding protein
[70]		P49006	MRP_HUMAN	MARCKSL1	1	4.1	4.07	3.9e-8	494.2553	2	1.0	LSGLSFKR	LSGLS(Phospho)FKR	Phospho@104=6	8	V20130429-03_FTMSms2hcd	30.269	100	107	33.5	3.9e-8	6.9e-11	1	19528.9	HUMAN	MARCKS-related protein
[71]		Q9NR30	DDX21_HUMAN	DDX21	1	1.4	3.94	2.4e-7	633.3613	2	1.0	TFSFAIPLIEK	TFSFAIPLIEK		11	V20130429-03_FTMSms2hcd	62.415	237	247	36.4	2.4e-7	7.8e-10	1	87345.1	HUMAN	Nucleolar RNA helicase 2
[72]		P62847	RS24_HUMAN	RPS24	1	9.0	3.85	1.9e-8	699.8745	2	0.079	TTPDVIFVFGFR	TTPDVIFVFGFR		12	V20130429-03_FTMSms2hcd	65.895	50	61	29.6	1.9e-8	3.4e-11	1	15423.3	HUMAN	40S ribosomal protein S24
[73]		P39687	AN32A_HUMAN	ANP32A	1	13.7	3.71	5.3e-9	1236.6458	3	8.8	SNEGKLEGLTDEFEELEFLSTINVGLTSIANLPK	SNEGKLEGLTDEFEELEFLSTINVGLTSIANLPK		34	V20130429-03_FTMSms2hcd	77.562	29	62	25.2	5.3e-9	1.3e-11	1	28585.6	HUMAN	Acidic leucine-rich nuclear phosphoprotein 32 family member A
[74]		P46778	RL21_HUMAN	RPL21	1	11.2	3.59	2.2e-8	1047.5112	2	2.5	TNGKEPELLEPIPYEFMA	TNGKEPELLEPIPYEFM(Oxidation)A	Oxidation@159	18	V20130429-03_FTMSms2hcd	57.638	143	160	27.4	2.2e-8	2.2e-11	1	18565.0	HUMAN	60S ribosomal protein L21
[75]		P46776	RL27A_HUMAN	RPL27A	1	7.4	3.47	2.0e-8	556.3273	2	0.30	TGAAPIIDVVR	TGAAPIIDVVR		11	V20130429-03_FTMSms2hcd	39.364	95	105	25.9	2.0e-8	9.4e-11	1	16561.5	HUMAN	60S ribosomal protein L27a
[76]		P35232	PHB_HUMAN	PHB	1	10.7	3.36	1.3e-8	1041.8885	3	8.4	AATFGLILDDVSLTHLTFGKEFTEAVEAK	AATFGLILDDVSLTHLTFGKEFTEAVEAK		29	V20130429-03_FTMSms2hcd	73.502	158	186	23.9	1.3e-8	3.2e-11	1	29804.3	HUMAN	Prohibitin
[77]		P05387	RLA2_HUMAN	RPLP2	1	10.4	3.35	3.0e-7	628.8458	2	-0.13	NIEDVIAQGIGK	NIEDVIAQGIGK		12	V20130429-03_FTMSms2hcd	47.942	50	61	31.1	3.0e-7	5.7e-10	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[78]		P56537	IF6_HUMAN	EIF6	1	9.8	3.31	2.6e-8	862.1255	3	6.0	TSIEDQDELSSLLQVPLVAGTVNR	TSIEDQDELSSLLQVPLVAGTVNR		24	V20130429-03_FTMSms2hcd	68.573	165	188	24.9	2.6e-8	5.4e-11	1	26599.3	HUMAN	Eukaryotic translation initiation factor 6
[79]		P29692	EF1D_HUMAN	EEF1D	1	3.6	3.01	1.0e-6	536.7748	2	0.13	MATNFLAHEK	M(Met-loss+Acetyl)ATNFLAHEK	Met-loss+Acetyl@1	10	V20130429-03_FTMSms2hcd	32.658	1	10	30.5	1.0e-6	1.7e-9	1	31122.1	HUMAN	Elongation factor 1-delta
[80]		P62851	RS25_HUMAN	RPS25	1	7.2	2.91	7.1e-6	486.7906	2	1.5	AALQELLSK	AALQELLSK		9	V20130429-03_FTMSms2hcd	39.673	86	94	34.1	7.1e-6	1.5e-8	1	13742.2	HUMAN	40S ribosomal protein S25
[81]		P62913	RL11_HUMAN	RPL11	1	7.9	2.89	9.5e-8	773.9297	2	3.0	VLEQLTGQTPVFSK	VLEQLTGQTPVFSK		14	V20130429-03_FTMSms2hcd	42.783	39	52	23.8	9.5e-8	2.2e-10	1	20252.6	HUMAN	60S ribosomal protein L11
[82]		P67809	YBOX1_HUMAN	YBX1	1	7.4	2.75	5.5e-8	928.7385	3	-1.5	EDGNEEDKENQGDETQGQQPPQRR	EDGNEEDKENQGDETQGQQPPQRR		24	V20130429-03_FTMSms2hcd	11.056	257	280	21.1	5.5e-8	5.6e-11	1	35924.5	HUMAN	Nuclease-sensitive element-binding protein 1
[83]		P05386	RLA1_HUMAN	RPLP1	1	14.0	2.47	4.9e-7	851.9529	2	2.0	AAGVNVEPFWPGLFAK	AAGVNVEPFWPGLFAK		16	V20130429-03_FTMSms2hcd	64.709	34	49	23.4	4.9e-7	7.5e-10	1	11514.0	HUMAN	60S acidic ribosomal protein P1
[84]		Q12882	DPYD_HUMAN	DPYD	2	1.5	1.28	8.7e-4	920.4274	2	14	SLSVNEMTLSTLKEK	SLSVNEMT(Phospho)LS(Phospho)TLKEK	Phospho@267&269|267&270|269&270	15	V20130429-03_FTMSms2hcd	28.706	260	274	29.1	8.7e-4	9.5e-7	1	111402.5	HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)]
[84]		Q12882	DPYD_HUMAN	DPYD	2	1.5	1.28	8.7e-4	928.4109	2	-0.79	SLSVNEMTLSTLKEK	S(Phospho)LSVNEM(Oxidation)T(Phospho)LSTLKEK	Oxidation@266;Phospho@260&262|260&267|260&269|260&270|262&267|262&269|262&270|267&269|267&270|269&270	15	V20130429-03_FTMSms2hcd	28.761	260	274	15.9	0.0033	3.8e-6	1	111402.5	HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)]
[85]		P06454	PTMA_HUMAN	PTMA	1	11.7	2.20	1.9e-6	719.2811	2	3.4	AAEDDEDDDVDTK	AAEDDEDDDVDTK		13	V20130429-03_FTMSms2hcd	9.881	91	103	23.8	1.9e-6	4.9e-9	1	12203.0	HUMAN	Prothymosin alpha
[86]		P17096	HMGA1_HUMAN	HMGA1	1	17.8	2.11	1.1e-6	799.6494	3	2.9	KLEKEEEEGISQESSEEEQ	KLEKEEEEGISQES(Phospho)S(Phospho)EEEQ	Phospho@102=15;Phospho@103=15	19	V20130429-03_FTMSms2hcd	21.553	89	107	21.8	1.1e-6	2.1e-9	1	11676.1	HUMAN	High mobility group protein HMG-I/HMG-Y
[87]		P04075	ALDOA_HUMAN	ALDOA	1	3.8	2.08	8.4e-7	549.6077	3	-0.43	LQSIGTENTEENRR	LQSIGTENTEENRR		14	V20130429-03_FTMSms2hcd	16.806	44	57	20.8	8.4e-7	1.0e-9	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[88]		P61604	CH10_HUMAN	HSPE1	1	6.9	2.01	6.8e-5	454.2553	2	-0.32	FLPLFDR	FLPLFDR		7	V20130429-03_FTMSms2hcd	49.421	9	15	30.4	6.8e-5	1.6e-7	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[89]		P16949	STMN1_HUMAN	STMN1	1	6.0	1.93	4.9e-5	537.7884	2	1.7	DLSLEEIQK	DLSLEEIQK		9	V20130429-03_FTMSms2hcd	35.745	44	52	28.8	4.9e-5	7.3e-8	2	17302.7	HUMAN	Stathmin
[89-1]	0	Q93045	STMN2_HUMAN	STMN2	1	5.0	1.93	4.9e-5	537.7884	2	1.7	DLSLEEIQK	DLSLEEIQK		9	V20130429-03_FTMSms2hcd	35.745	78	86	28.8	4.9e-5	7.3e-8	2	20828.2	HUMAN	Stathmin-2
[90]		P62826	RAN_HUMAN	RAN	1	6.5	1.92	2.5e-6	595.6415	3	-1.1	SNYNFEKPFLWLAR	SNYNFEKPFLWLAR		14	V20130429-03_FTMSms2hcd	58.376	153	166	21.8	2.5e-6	3.4e-9	1	24423.3	HUMAN	GTP-binding nuclear protein Ran
[91]		P07305	H10_HUMAN	H1F0	1	7.2	1.85	5.2e-7	745.8613	2	-0.14	MTENSTSAPAAKPK	M(Acetyl+Oxidation)TENSTSAPAAKPK		14	V20130429-03_FTMSms2hcd	11.620	1	14	17.4	5.2e-7	6.3e-10	1	20863.1	HUMAN	Histone H1.0
[92]		P26373	RL13_HUMAN	RPL13	1	3.8	1.82	1.3e-5	475.7502	2	-1.1	GFSLEELR	GFSLEELR		8	V20130429-03_FTMSms2hcd	42.293	75	82	24.7	1.3e-5	2.5e-8	1	24261.7	HUMAN	60S ribosomal protein L13
[93]		Q9BZ72	PITM2_HUMAN	PITPNM2	1	0.5	1.73	6.9e-4	435.2584	2	0.49	LEPLLER	LEPLLER		7	V20130429-03_FTMSms2hcd	30.934	769	775	33.0	6.9e-4	3.0e-6	1	148934.5	HUMAN	Membrane-associated phosphatidylinositol transfer protein 2
[94]		Q6ZQQ6	WDR87_HUMAN	WDR87	1	0.3	1.37	1.8e-5	610.8135	2	0.50	EEKALNLEMK	EEKALNLEM(Oxidation)K	Oxidation@1967	10	V20130429-03_FTMSms2hcd	37.782	1959	1968	20.8	1.8e-5	2.6e-8	1	333188.0	HUMAN	WD repeat-containing protein 87
[95]		Q6UXB4	CLC4G_HUMAN	CLEC4G	1	3.8	1.34	9.1e-5	597.3411	2	9.4	AALLDGHDLLR	AALLDGHDLLR		11	V20130429-03_FTMSms2hcd	37.467	61	71	24.4	9.1e-5	2.8e-7	1	32562.0	HUMAN	C-type lectin domain family 4 member G
[96]		Q8TEM1	PO210_HUMAN	NUP210	1	0.5	1.32	4.5e-6	511.2885	2	2.0	VPVVHVDEK	VPVVHVDEK		9	V20130429-03_FTMSms2hcd	36.210	1329	1337	17.1	4.5e-6	1.2e-8	1	205112.9	HUMAN	Nuclear pore membrane glycoprotein 210
[97]		P04083	ANXA1_HUMAN	ANXA1	1	4.0	1.26	9.4e-7	515.2946	3	0.16	GVDEATIIDILTKR	GVDEATIIDILTKR		14	V20130429-03_FTMSms2hcd	58.992	59	72	12.9	9.4e-7	2.9e-9	1	38714.6	HUMAN	Annexin A1
[98]		P41250	SYG_HUMAN	GARS	1	1.8	1.22	1.6e-5	729.3971	2	2.9	TFFSFPAVVAPFK	TFFSFPAVVAPFK		13	V20130429-03_FTMSms2hcd	67.395	603	615	19.1	1.6e-5	3.0e-8	1	83166.3	HUMAN	Glycine--tRNA ligase
[99]		P46777	RL5_HUMAN	RPL5	1	6.1	1.22	3.5e-4	624.0033	3	3.3	VGLTNYAAAYCTGLLLAR	VGLTNYAAAYCTGLLLAR		18	V20130429-03_FTMSms2hcd	67.813	90	107	26.3	3.5e-4	6.7e-7	1	34362.9	HUMAN	60S ribosomal protein L5
[100]		P02768	ALBU_HUMAN	ALB	1	1.1	1.20	0.0021	464.2500	2	-0.78	YLYEIAR	YLYEIAR		7	V20130429-03_FTMSms2hcd	31.409	162	168	30.4	0.0021	5.2e-6	1	69367.4	HUMAN	Serum albumin
[101]		Q00610	CLH1_HUMAN	CLTC	1	0.7	1.19	1.1e-4	652.8339	2	0.91	NNLAGAEELFAR	NNLAGAEELFAR		12	V20130429-03_FTMSms2hcd	43.854	355	366	23.4	1.1e-4	1.6e-7	1	191616.3	HUMAN	Clathrin heavy chain 1
[102]		O95466	FMNL_HUMAN	FMNL1	1	0.9	1.17	1.5e-4	569.2690	2	0.65	RDSELGPGVK	RDS(Phospho)ELGPGVK	Phospho@624	10	V20130429-03_FTMSms2hcd	17.267	622	631	23.9	1.5e-4	2.6e-7	1	121854.6	HUMAN	Formin-like protein 1
[103]		O14979	HNRDL_HUMAN	HNRPDL	1	1.9	1.12	1.0e-4	457.7600	2	-0.80	GFGFVLFK	GFGFVLFK		8	V20130429-03_FTMSms2hcd	57.841	190	197	22.4	1.0e-4	2.6e-7	2	46437.9	HUMAN	Heterogeneous nuclear ribonucleoprotein D-like
[103-1]	0	Q14103	HNRPD_HUMAN	HNRNPD	1	2.3	1.12	1.0e-4	457.7600	2	-0.80	GFGFVLFK	GFGFVLFK		8	V20130429-03_FTMSms2hcd	57.841	139	146	22.4	1.0e-4	2.6e-7	2	38434.5	HUMAN	Heterogeneous nuclear ribonucleoprotein D0
[104]		Q5VVM6	CCD30_HUMAN	CCDC30	1	1.5	1.11	1.4e-4	695.3253	2	5.8	EGQKEEGSQQNR	EGQKEEGSQQNR		12	V20130429-03_FTMSms2hcd	25.517	166	177	23.1	1.4e-4	1.8e-7	1	91334.1	HUMAN	Coiled-coil domain-containing protein 30
[105]		O60333	KIF1B_HUMAN	KIF1B	1	0.6	1.11	6.8e-7	727.2900	2	-8.5	LDLMREMYDR	LDLM(Oxidation)REM(Oxidation)Y(Phospho)DR	Oxidation@852;Oxidation@855;Phospho@856	10	V20130429-03_FTMSms2hcd	29.439	849	858	10.6	6.8e-7	1.6e-9	2	204478.0	HUMAN	Kinesin-like protein KIF1B
[105-1]	0	Q12756	KIF1A_HUMAN	KIF1A	1	0.6	1.11	6.8e-7	727.2900	2	-8.5	LDLMREMYDR	LDLM(Oxidation)REM(Oxidation)Y(Phospho)DR	Oxidation@812;Oxidation@815;Phospho@816	10	V20130429-03_FTMSms2hcd	29.439	809	818	10.6	6.8e-7	1.6e-9	2	191065.8	HUMAN	Kinesin-like protein KIF1A
[106]		A6NHP6	YR011_HUMAN		1	3.1	1.11	6.8e-7	727.2900	2	-7.4	LDMKEIHTYK	LDM(Oxidation)KEIHT(Phospho)Y(Phospho)K	Oxidation@175;Phospho@180;Phospho@181	10	V20130429-03_FTMSms2hcd	29.439	173	182	10.6	6.8e-7	1.6e-9	2	37918.4	HUMAN	NPIP-like protein LOC729602
[106-1]	0	A8MZ50	NPIL4_HUMAN		1	3.0	1.11	6.8e-7	727.2900	2	-7.4	LDMKEIHTYK	LDM(Oxidation)KEIHT(Phospho)Y(Phospho)K	Oxidation@175;Phospho@180;Phospho@181	10	V20130429-03_FTMSms2hcd	29.439	173	182	10.6	6.8e-7	1.6e-9	2	38380.9	HUMAN	Putative NPIP-like protein ENSP00000381263
[107]		Q58FF7	H90B3_HUMAN	HSP90AB3P	1	2.2	1.08	2.3e-6	718.8185	2	-6.3	IKDVGSDEEDDSK	IKDVGSDEEDDSK		13	V20130429-03_FTMSms2hcd	23.485	229	241	13.2	2.3e-6	3.6e-9	1	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[108]		Q14315	FLNC_HUMAN	FLNC	1	0.3	1.06	4.2e-5	433.6873	2	-11	ASGPGLER	AS(Phospho)GPGLER	Phospho@1161	8	V20130429-03_FTMSms2hcd	12.998	1160	1167	19.8	4.2e-5	1.6e-7	1	291024.6	HUMAN	Filamin-C
[109]		Q8NDV7	TNR6A_HUMAN	TNRC6A	2	1.7	0.63	4.4e-5	1136.9758	2	15	MEIDDGTSAWGDPSKYNYK	M(Oxidation)EIDDGTSAWGDPSKY(Phospho)NYK	Oxidation@999;Phospho@1014|1016	19	V20130429-03_FTMSms2hcd	43.828	999	1017	12.2	4.4e-5	5.7e-8	1	210298.9	HUMAN	Trinucleotide repeat-containing gene 6A protein
[109]		Q8NDV7	TNR6A_HUMAN	TNRC6A	2	1.7	0.63	4.4e-5	836.3619	2	-10	LEEKGTGESQSRDR	LEEKGTGES(Phospho)QSRDR	Phospho@687|690|692	14	V20130429-03_FTMSms2hcd	27.311	682	695	15.6	1.5e-4	2.1e-7	1	210298.9	HUMAN	Trinucleotide repeat-containing gene 6A protein
[110]		P56181	NDUV3_HUMAN	NDUFV3	1	26.9	0.86	4.4e-5	778.3752	4	-6.5	AGALKTMLQEAQVFRGLASTVSLSAESGK	AGALKT(Phospho)MLQEAQVFRGLASTVS(Phospho)LSAESGK	Phospho@17=7;Phospho@33|35|38	29	V20130429-03_FTMSms2hcd	58.496	12	40	17.9	4.4e-5	4.7e-8	1	11940.6	HUMAN	NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial
[111]		Q86UP3	ZFHX4_HUMAN	ZFHX4	1	0.3	0.83	2.4e-5	723.3582	2	2.9	LQIHSQYHAIR	LQIHSQY(Phospho)HAIR	Phospho@1373=12	11	V20130429-03_FTMSms2hcd	43.113	1367	1377	16.1	2.4e-5	3.1e-8	1	393733.1	HUMAN	Zinc finger homeobox protein 4
[112]		Q86UQ4	ABCAD_HUMAN	ABCA13	1	0.1	0.82	9.4e-4	426.2716	2	1.2	HILDIIK	HILDIIK		7	V20130429-03_FTMSms2hcd	36.605	994	1000	24.7	9.4e-4	1.3e-5	1	576164.4	HUMAN	ATP-binding cassette sub-family A member 13
[113]		Q96MH6	TMM68_HUMAN	TMEM68	1	3.7	0.64	0.025	665.3607	2	-4.0	IPGNIMSALLER	IPGNIM(Oxidation)SALLER	Oxidation@316	12	V20130429-03_FTMSms2hcd	20.251	311	322	30.6	0.025	4.4e-5	1	37425.1	HUMAN	Transmembrane protein 68
[114]		Q8N187	AL2S8_HUMAN	ALS2CR8	1	1.0	0.63	1.0e-4	464.2023	2	4.5	VETNQTR	VETNQT(Phospho)R	Phospho@536=23	7	V20130429-03_FTMSms2hcd	14.537	531	537	17.6	1.0e-4	2.5e-7	1	80698.6	HUMAN	Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein
[115]		Q68DN1	CB016_HUMAN	C2orf16	2	0.6	0.42	7.7e-5	709.2814	2	10	IGATQTSTASLK	IGATQT(Phospho)S(Phospho)TAS(Phospho)LK	Phospho@1332&1333&1334|1332&1333&1336|1332&1334&1336|1333&1334&1336	12	V20130429-03_FTMSms2hcd	15.324	1327	1338	14.8	7.7e-5	2.0e-7	1	224323.2	HUMAN	Uncharacterized protein C2orf16
[115]		Q68DN1	CB016_HUMAN	C2orf16	2	0.6	0.42	7.7e-5	473.1898	3	9.6	IGATQTSTASLK	IGATQT(Phospho)S(Phospho)T(Phospho)ASLK	Phospho@1332&1333&1334|1332&1333&1336|1332&1334&1336|1333&1334&1336	12	V20130429-03_FTMSms2hcd	15.377	1327	1338	13.6	2.0e-4	5.2e-7	1	224323.2	HUMAN	Uncharacterized protein C2orf16
[116]		Q8N3U4	STAG2_HUMAN	STAG2	1	0.8	0.58	8.0e-4	617.8675	2	-8.2	HLDALLRQIR	HLDALLRQIR		10	V20130429-03_FTMSms2hcd	47.437	608	617	21.9	8.0e-4	4.0e-6	1	141327.7	HUMAN	Cohesin subunit SA-2
[117]		P46783	RS10_HUMAN	RPS10	1	5.5	0.58	3.7e-4	555.3331	2	-1.4	IAIYELLFK	IAIYELLFK		9	V20130429-03_FTMSms2hcd	65.210	9	17	20.1	3.7e-4	2.4e-6	1	18897.9	HUMAN	40S ribosomal protein S10
[118]		Q9Y6I7	WSB1_HUMAN	WSB1	1	2.6	0.53	4.8e-5	646.3244	2	-3.7	MASFPPRVNEK	M(Oxidation)ASFPPRVNEK	Oxidation@1	11	V20130429-03_FTMSms2hcd	56.387	1	11	14.8	4.8e-5	6.7e-8	1	47432.6	HUMAN	WD repeat and SOCS box-containing protein 1
[119]		Q0D2J5	ZN763_HUMAN	ZNF763	1	2.8	0.50	1.4e-4	668.3291	2	12	ALSYKFSNTPK	ALSYKFS(Phospho)NTPK	Phospho@382|384	11	V20130429-03_FTMSms2hcd	30.392	376	386	17.0	1.4e-4	2.0e-7	1	46099.6	HUMAN	Zinc finger protein 763
[120]		O14744	ANM5_HUMAN	PRMT5	1	3.3	0.45	9.6e-5	775.7700	3	-1.2	AAILPTSIFLTNKKGFPVLSK	AAILPTSIFLTNKKGFPVLS(Phospho)K	Phospho@247=13	21	V20130429-03_FTMSms2hcd	60.249	228	248	15.6	9.6e-5	4.8e-7	1	72684.5	HUMAN	Protein arginine N-methyltransferase 5
[121]		P18124	RL7_HUMAN	RPL7	1	4.4	0.43	1.7e-4	585.8461	2	0.70	IALTDNALIAR	IALTDNALIAR		11	V20130429-03_FTMSms2hcd	40.775	167	177	16.8	1.7e-4	5.9e-7	1	29226.0	HUMAN	60S ribosomal protein L7
[122]		P08069	IGF1R_HUMAN	IGF1R	1	0.5	0.41	1.1e-4	523.7291	2	5.2	YRPPDYR	YRPPDY(Phospho)R	Phospho@517=43	7	V20130429-03_FTMSms2hcd	16.236	512	518	15.5	1.1e-4	2.3e-7	1	154794.5	HUMAN	Insulin-like growth factor 1 receptor
[123]		Q16288	NTRK3_HUMAN	NTRK3	1	1.7	0.39	2.1e-4	415.4509	4	20	MDVSLCPAKCSFWR	M(Oxidation)DVSLCPAKCSFWR	Oxidation@1	14	V20130429-03_FTMSms2hcd	18.280	1	14	16.8	2.1e-4	2.5e-7	1	94429.1	HUMAN	NT-3 growth factor receptor
[124]		Q9Y6A5	TACC3_HUMAN	TACC3	1	0.8	0.39	4.0e-4	433.2243	2	-0.098	EVIEGYR	EVIEGYR		7	V20130429-03_FTMSms2hcd	19.780	734	740	18.3	4.0e-4	8.2e-7	1	90360.4	HUMAN	Transforming acidic coiled-coil-containing protein 3
[125]		Q4G0M1	F132B_HUMAN	FAM132B	1	4.0	0.36	6.1e-4	750.3652	2	15	AGPAARPPEPTAER	AGPAARPPEPT(Phospho)AER	Phospho@69	14	V20130429-03_FTMSms2hcd	24.987	59	72	19.1	6.1e-4	7.7e-7	1	37279.2	HUMAN	Protein FAM132B
[126]		Q496Y0	LONF3_HUMAN	LONRF3	1	1.6	0.35	2.6e-4	735.8710	2	-13	AQLPFLAMRSLK	AQLPFLAM(Oxidation)RS(Phospho)LK	Oxidation@737;Phospho@739	12	V20130429-03_FTMSms2hcd	62.298	730	741	16.9	2.6e-4	3.2e-7	1	84490.4	HUMAN	LON peptidase N-terminal domain and RING finger protein 3
[127]		O75822	EIF3J_HUMAN	EIF3J	1	5.0	0.34	8.5e-5	780.4222	2	-6.2	SLYYASFLEVLVR	SLYYASFLEVLVR		13	V20130429-03_FTMSms2hcd	73.205	173	185	14.2	8.5e-5	1.4e-7	1	29062.6	HUMAN	Eukaryotic translation initiation factor 3 subunit J
[128]		Q9NYQ8	FAT2_HUMAN	FAT2	1	0.3	0.33	4.7e-4	624.8294	2	5.7	VVSGNEQGRFR	VVSGNEQGRFR		11	V20130429-03_FTMSms2hcd	10.896	3255	3265	18.1	4.7e-4	7.2e-7	1	479321.3	HUMAN	Protocadherin Fat 2
[129]		Q9NYV4	CDK12_HUMAN	CDK12	1	0.6	0.30	0.0014	544.7551	2	-9.8	SSSPFLSKR	S(Phospho)SSPFLSKR	Phospho@332|333|334	9	V20130429-03_FTMSms2hcd	23.610	332	340	20.4	0.0014	2.4e-6	1	164155.9	HUMAN	Cyclin-dependent kinase 12
[130]		Q8NG11	TSN14_HUMAN	TSPAN14	1	3.0	0.26	0.0075	416.7432	2	2.0	GVLSDLTK	GVLSDLTK		8	V20130429-03_FTMSms2hcd	45.193	45	52	23.9	0.0075	1.5e-5	1	30691.1	HUMAN	Tetraspanin-14
[131]		Q5T0W9	FA83B_HUMAN	FAM83B	1	1.3	0.26	1.7e-4	491.9543	3	12	SSLVFKPTLPEQK	SSLVFKPTLPEQK		13	V20130429-03_FTMSms2hcd	32.044	542	554	15.0	1.7e-4	6.5e-7	1	114800.1	HUMAN	Protein FAM83B
[132]		Q75QN2	INT8_HUMAN	INTS8	1	0.7	0.25	0.0013	412.2558	2	0.86	LPDIPLR	LPDIPLR		7	V20130429-03_FTMSms2hcd	34.444	650	656	19.8	0.0013	1.3e-5	1	113089.1	HUMAN	Integrator complex subunit 8
[133]		Q6UN15	FIP1_HUMAN	FIP1L1	1	1.2	0.25	0.0026	394.2010	2	0.34	AESPDLR	AESPDLR		7	V20130429-03_FTMSms2hcd	15.826	302	308	21.3	0.0026	6.9e-6	1	66526.9	HUMAN	Pre-mRNA 3'-end-processing factor FIP1
[134]		P56715	RP1_HUMAN	RP1	1	0.6	0.23	0.0012	776.9464	2	-6.6	VPLPFGVRNISTPR	VPLPFGVRNISTPR		14	V20130429-03_FTMSms2hcd	27.988	74	87	19.4	0.0012	6.2e-6	1	240663.4	HUMAN	Oxygen-regulated protein 1
[135]		Q9NXG0	CNTLN_HUMAN	CNTLN	1	0.7	0.22	0.0083	376.5486	3	2.9	RQVAEANALR	RQVAEANALR		10	V20130429-03_FTMSms2hcd	16.339	776	785	23.8	0.0083	2.3e-5	1	161604.6	HUMAN	Centlein
[136]		P84074	HPCA_HUMAN	HPCA	1	5.2	0.20	0.021	643.8456	2	-3.6	LRPEMLQDLR	LRPEM(Oxidation)LQDLR	Oxidation@12	10	V20130429-03_FTMSms2hcd	16.005	8	17	25.8	0.021	3.4e-5	1	22427.6	HUMAN	Neuron-specific calcium-binding protein hippocalcin
[137]		Q8IVF2	AHNK2_HUMAN	AHNAK2	1	0.2	0.16	0.0028	687.3398	2	0.80	LPEGPVPEGASLK	LPEGPVPEGAS(Phospho)LK	Phospho@4046	13	V20130429-03_FTMSms2hcd	16.089	4036	4048	20.6	0.0028	3.6e-6	1	616634.7	HUMAN	Protein AHNAK2
[138]		Q9C0D5	TANC1_HUMAN	TANC1	1	0.9	0.15	0.0024	1056.9922	2	-7.0	FPREGFGEDMRPFNELR	FPREGFGEDM(Oxidation)RPFNELR	Oxidation@1328	17	V20130429-03_FTMSms2hcd	56.266	1319	1335	20.1	0.0024	2.4e-6	1	202221.0	HUMAN	Protein TANC1
[139]		Q9H3R0	KDM4C_HUMAN	KDM4C	1	1.2	0.14	4.9e-5	740.3221	2	9.2	RVSGACIQCSYGR	RVSGACIQCSY(Phospho)GR	Phospho@829=8	13	V20130429-03_FTMSms2hcd	32.082	819	831	10.9	4.9e-5	7.8e-8	1	119982.9	HUMAN	Lysine-specific demethylase 4C
[140]		P62753	RS6_HUMAN	RPS6	1	3.2	0.13	6.3e-4	494.7510	2	0.16	LIEVDDER	LIEVDDER		8	V20130429-03_FTMSms2hcd	22.470	15	22	16.8	6.3e-4	1.2e-6	1	28680.9	HUMAN	40S ribosomal protein S6
[141]		Q9Y4B5	CC165_HUMAN	CCDC165	1	1.5	0.06	6.2e-4	928.4310	3	7.2	GSGVTSSPHKCLTPKAGGGATPVSSPSR	GSGVTSSPHKCLT(Phospho)PKAGGGATPVS(Phospho)SPSR	Phospho@1658=21;Phospho@1666|1669|1670|1672	28	V20130429-03_FTMSms2hcd	38.190	1646	1673	16.1	6.2e-4	5.8e-7	1	208750.8	HUMAN	Coiled-coil domain-containing protein 165
[142]		Q14847	LASP1_HUMAN	LASP1	1	5.7	0.05	1.3e-4	784.3690	2	-0.081	TGDTGMLPANYVEAI	TGDTGM(Oxidation)LPANYVEAI	Oxidation@252	15	V20130429-03_FTMSms2hcd	48.938	247	261	12.2	1.3e-4	1.5e-7	1	29717.4	HUMAN	LIM and SH3 domain protein 1
[143]		Q14966	ZN638_HUMAN	ZNF638	1	0.7	0.05	4.7e-4	616.9543	3	18	RSRSPMHYMYRPR	RS(Phospho)RSPM(Oxidation)HYM(Oxidation)YRPR	Oxidation@512;Oxidation@515;Phospho@508|510	13	V20130429-03_FTMSms2hcd	15.165	507	519	15.3	4.7e-4	5.1e-7	1	220626.6	HUMAN	Zinc finger protein 638
[144]		Q8TCU4	ALMS1_HUMAN	ALMS1	1	0.3	0.04	2.5e-4	586.3220	2	4.3	ISTVIGPNDQK	ISTVIGPNDQK		11	V20130429-03_FTMSms2hcd	51.470	2026	2036	13.8	2.5e-4	4.6e-7	1	460968.5	HUMAN	Alstrom syndrome protein 1
[145]		Q96HU1	SGSM3_HUMAN	SGSM3	1	1.3	0.02	0.0047	407.8871	3	-0.52	FVEVLDERSK	FVEVLDERSK		10	V20130429-03_FTMSms2hcd	19.044	533	542	20.4	0.0047	8.2e-6	1	85354.6	HUMAN	Small G protein signaling modulator 3
